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ABSTRACT   
Metabolomics provides a method to study the dynamics of cellular function by 
adopting a systems biology approach to the analysis of small molecule metabolites found 
in various bio-fluids and tissue locations. Chapters one and two of this thesis explore the 
theory behind metabolomics and reviews representative studies applying NMR 
metabolomics to neuroscience. Chapter three presents the results from an experiment 
investigating the alterations of metabolic by-products found in urine caused by both 
cumulative and remote ancestral prenatal maternal stress. Chapter four explores the 
results of a similar experiment where the liver tissue from offspring of either cumulative 
or remote ancestral prenatal maternal stress were analysed. Chapter five is a general 
discussion and conclusion of the results from both experiments and explores how both 
sets of results indicate an alteration in the stress response of the offspring.  
   
  v 
ACKNOWLEDGEMENTS 
 
 I would first like to thank my wife, whose support and encouragement helped me 
get to where I am today, and my son who has no idea the extent to which he makes me 
strive to succeed.  
 I would also like to thank Anthony Montina for the guidance he provided as we 
learned together what metabolomics is. Thanks is especially due to Dr. Gerlinde Metz, 
my supervisor, for taking me on as a student and encouraging me to learn new things.  
  
  vi 
Table of Contents 
ABSTRACT.........................................................................................................................iv 
ACKNOWLEDGEMENTS ................................................................................................. v 
CHAPTER 1: INTRODUCTION TO NMR AND METABOLOMICS ............................. 1 
1.0 Overview ................................................................................................................... 2 
1.1 Systems Biology ....................................................................................................... 3 
1.2 Metabolic Phenotype ................................................................................................ 5 
1.3 Metabolomics............................................................................................................ 6 
CHAPTER 2: Methods of 1H NMR Metabolomics............................................................. 8 
2.0 Nuclear Magnetic Resonance Spectroscopy ............................................................. 9 
2.0.1 Historical Findings in Magnetic Resonance ...................................................... 9 
2.1 Current NMR Theory.............................................................................................. 12 
2.1.1 Properties of Subatomic Particles .................................................................... 12 
2.1.2 Mass and Charge .............................................................................................. 12 
2.1.3 Spin .................................................................................................................. 13 
2.1.4 Magnetism........................................................................................................ 13 
2.1.5 Detecting the NMR Signal ............................................................................... 18 
2.1.6 Chemical Shift  ................................................................................................. 22 
2.1.7 J-Coupling ........................................................................................................ 24 
2.1.8 Receiver Gain................................................................................................... 27 
2.2 Metabolomics Methods........................................................................................... 28 
2.2.1 Sample Collection and Storage ........................................................................ 29 
2.3 Sample Types and Preparation................................................................................ 29 
2.3.1 Urine................................................................................................................. 31 
2.3.2 Blood ................................................................................................................ 32 
2.3.3 Cerebrospinal Fluid.......................................................................................... 34 
2.3.4 Solid Tissue...................................................................................................... 35 
2.4 Experimental Platforms .......................................................................................... 36 
2.4.1 Nuclear Magnetic Resonance Protocols .......................................................... 36 
2.4.2 Mass Spectrometry Approaches ...................................................................... 37 
2.4.3 Technological Comparisons............................................................................. 37 
2.4.4 Sample Preparation .......................................................................................... 38 
2.4.5 Reproducibility of Results ............................................................................... 38 
2.4.6 Quantitative Analysis ....................................................................................... 39 
2.4.7 Non-Destructive Procedures ............................................................................ 39 
2.4.8 Sensitivity ........................................................................................................ 40 
2.4.9 Single-Step Analysis Procedures ..................................................................... 41 
2.4.10 Time Considerations ...................................................................................... 42 
2.4.11 Cost Effectiveness.......................................................................................... 42 
2.5 Data Analysis .......................................................................................................... 42 
2.5.1 Profiling Approach........................................................................................... 42 
2.5.2 Targeted Analysis ............................................................................................ 43 
2.5.3 Binning............................................................................................................. 43 
2.5.4 Normalization................................................................................................... 45 
2.5.5 Scaling.............................................................................................................. 46 
2.5.6 Multivariate Statistics ...................................................................................... 47 
2.5.7 Variable Selection ............................................................................................ 49 
  vii 
2.5.8 Pathway Analysis ............................................................................................. 51 
2.6 Applications of NMR Metabolomics to Neuroscience ........................................... 51 
2.6.1 Animal Models using NMR Metabolomics ..................................................... 52 
2.6.2 Human Studies of NMR Metabolomics........................................................... 54 
2.6.3 Discussion ........................................................................................................ 58 
CHAPTER 3: Stress Transgenerationally Programs Metabolic Pathways Linked to Altered 
Mental Health..................................................................................................................... 61 
3.0 Introduction ............................................................................................................. 62 
3.1 Materials and Methods............................................................................................ 64 
3.1.1 Animals ............................................................................................................ 64 
3.1.2 Experimental Design........................................................................................ 64 
3.1.3 Stress Procedure ............................................................................................... 65 
3.1.4 Behavioural Testing ......................................................................................... 66 
3.1.5 Sample Collection and Preparation.................................................................. 66 
3.1.6 NMR Data Acquisition and Processing ........................................................... 67 
3.1.7 Statistical Analysis ........................................................................................... 67 
3.1.8 Metabolite Identification.................................................................................. 69 
3.2 Results and Discussion ........................................................................................... 69 
3.2.1 Metabolite Identification and Selection ........................................................... 69 
3.2.2 Metabolic Pathway Analysis............................................................................ 76 
3.2.3 Behavioural Phenotype .................................................................................... 79 
3.3 Conclusions ............................................................................................................. 80 
CHAPTER 4: Transgenerational Stress Programming of Liver Metabolome ................... 82 
4.0 Introduction ............................................................................................................. 83 
4.1 Methods................................................................................................................... 84 
4.1.1 Animals ............................................................................................................ 84 
4.1.2 Experimental Design........................................................................................ 84 
4.1.3 Stress Procedure ............................................................................................... 84 
4.1.4 Sample Collection and Preparation.................................................................. 85 
4.1.5 Liver Homogenization ..................................................................................... 85 
4.1.6 NMR Data Acquisition and Processing ........................................................... 86 
4.1.7 Statistical Analysis ........................................................................................... 86 
4.1.8 Metabolite Identification.................................................................................. 87 
4.2 Results and Discussion ........................................................................................... 88 
4.3 Conclusion .............................................................................................................. 98 
Chapter 5: General Discussion and Conclusions ............................................................... 99 
5.1 Summary ............................................................................................................... 100 
5.2 Ancestral Stress Alters Metabolism ...................................................................... 100 
5.3 Limitations and Considerations for Future Research............................................ 101 
5.4 Conclusions ........................................................................................................... 102 
References ........................................................................................................................ 102 
 
  
  viii 
 
Table of Figures 
Figure 1. Illustration of the net magnetization being composed of parallel and anti-
parallel components, with Bo pointing along the positive z-axis. ..................................... 16 
Figure 2. Illustration of Zeeman splitting with formulas correlating the Larmour 
frequency to the energy difference between the two energy levels.  .................................. 17 
Figure 3. FID of a single frequency and the resulting FT.  ................................................ 21 
Figure 4. FID of real data and the resulting FT showing a portion of the spectrum. ........ 21 
Figure 5. Arginine proton spectrum at 300MHz. .............................................................. 25 
Figure 6. Arginine proton spectrum at 700MHz. .............................................................. 25 
Figure 7. A region of multiple spectra stacked on top of each other and binned to include 
entire signals in a single bin. .............................................................................................. 44 
Figure 8. Illustration of spectra being binned and the dimensions that normalization and 
scaling work it. Normalization functions on each individual spectrum, while scaling 
functions on a bin single bin across all the spectra.  ........................................................... 46 
Figure 9. Illustration of the experimental design that tested the F4 offspring of a lineage 
in which stress occurred in each generation (multigenerational stress, SSSS) or in which 
stress was limited to the first parental generation (transgenerational stress, SNNN. ........ 65 
Figure 10. Scores plots showing components 1 (X-axis) and 2 (Y-axis) of the PCA 
analysis for (A and C) F4-SSSS multigenerationally stressed lineage versus controls and 
(B and D) F4-SNNN transgenerationally stressed lineage versus controls. A and B 
provide the result of the analysis when on the metabolites identified by VIAVC were 
considered. The percentages shown along each axis indicate the amount of variance in the 
data set given by each componenet and the shaded ellipses designate the 95% confidence 
interval for each group. The controls are indicated by the red circles, the F4-SSSS by 
green triangles, and the F4-SNNN by green diamonds. .................................................... 71 
Figure 11. Heat maps for (A) F4-SSSS multigenerationally stressed lineage versus 
controls and (B) F4-SNNN transgenerationally stressed lineage versus controls. The X- 
and Y-axis show the class and the metabolite identity, respectively. These heat maps 
visually indicate either up- or down-regulation of the metabolites presented in Table 1. 
The legend corresponding to the class label and the heat map for both figures is shown to 
the right of figure B. Abbreviations: 1-MN, 1-methylnicotinamide, IMP, inosine 
monophospate. The labels 1-MN, 1-MN.1 and 1-MN.2, as well as Histamine and 
Histamine.1, correspond to different resonance peaks of the same metabolite. The 
dendrogram at the top of each heatmap illustrates the results of the unsupervised 
hierarchical clustering analysis.  ......................................................................................... 72 
Figure 12. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in table 1. The p-values for the 
metabolic pathways are color coded with dark red being highly significant and white 
being least significant. The category “Intracellular Signalling” stands for intracellular 
signalling through the H2 receptor and histamine.  ............................................................ 73 
  ix 
Figure 13. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in table 1. The p-values for the 
metabolic pathways are color coded with dark red being highly significant and white 
being least significant. The category “Intracellular Signalling” stands for intracellular 
signalling through the H2 receptor and histamine.  ............................................................ 77 
Figure 14. Pearson correlations to assess the relationship between  anxiety- like behaviour 
(i.e., average centre distance traveled) and the relative concentrations of histamine (A) 
and tyrosine (B). There were positive correlations between the distance score and 
histamine (r = 0.55, p = 0.0045), and tyrosine (r = 0.21, p = 0.177), indicating that a 
higher anxiety- like state was linked to lower histamine and tyrosine concentrations.  ...... 80 
Figure 15. PCA scores using all variables for female F4-SNNN (A) and F4-SSSS (B). 
Plots show components 1 (x-axis) and 2 (y-axis) with the percentage of the variance 
explained by each component labelled on the axis. Ovals indicate the 95% confidence 
interval. .............................................................................................................................. 88 
Figure 16. PCA scores using all variables for male F4-SNNN (A) and F4-SSSS (B). Plots 
show components 1 (x-axis) and 2 (y-axis) with the percentage of the variance explained 
by each component labelled on the axis. Ovals indicate the 95% confidence interval  ..... 89 
Figure 17. PCA scores using the optimal subset of variables for female F4-SNNN (A) 
and F4-SSSS (B). Plots show components 1 (x-axis) and 2 (y-axis) with the percentage of 
the variance explained by each component labelled on the axis. Ovals indicate the 95% 
confidence interval ............................................................................................................. 89 
Figure 18. PCA scores using the optimal subset of variables for male F4-SNNN (A) and 
F4-SSSS (B). Plots show components 1 (x-axis) and 2 (y-axis) with the percentage of the 
variance explained by each component labelled on the axis. Ovals indicate the 95% 
confidence interval ............................................................................................................. 90 
Figure 19. Heat maps for female (A) F4-SNNN multigenerationally stressed lineage 
versus controls and (B) F4-SSSS transgenerationally stressed lineage versus controls. The 
X- and Y-axis show the class and the metabolite identity, respectively. These heat maps 
visually indicate either up- or down-regulation of the metabolites presented in Table 3. 
The dendrogram at the top of each heatmap illustrates the results of the unsupervised 
hierarchical clustering analysis.  ......................................................................................... 90 
Figure 20. Heat maps for male (A) F4-SNNN multigenerationally stressed lineage versus 
controls and (B) F4-SSSS transgenerationally stressed lineage versus controls. The X- 
and Y-axis show the class and the metabolite identity, respectively. These heat maps 
visually indicate either up- or down-regulation of the metabolites presented in Table 3. 
The dendrogram at the top of each heatmap illustrates the results of the unsupervised 
hierarchical clustering analysis.  ......................................................................................... 91 
Figure 21. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in Table 3 for the Female SNNN 
group. The Pp-values for the metabolic pathways are color coded with dark red being h 93 
Figure 22. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in Table 3 for the Female SSSS 
  x 
group. The Pp-values for the metabolic pathways are color coded with dark red being 
highly significant and white being the least. ...................................................................... 94 
Figure 23. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in Table 3 for the Male SNNN 
group. The p-values for the metabolic pathways are color coded with dark red being 
highly significant and white being the least significant.  .................................................... 95 
Figure 24. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in Table 3 for the Male SSSS 
group. The p-values for the metabolic pathways are color coded with dark red being 
highly significant and white being the least significant.  .................................................... 96 
 
  
  xi 
List of Tables 
Table 1. Display of the percent differences and P-values of metabolites that were 
determined to be significant for at least one of the stress lineages based on the VIAVC 
analysis (Control, n=7; F4-SSSS, n=6; F4-SNNN, 
n=6)….………………………………………………………………53 
Table 2. Overview of the metabolic pathways that were altered by ancestral stress 
compared to non-stress controls. Total indicates the total number of metabolites listed in 
the pathways; hits indicate the number of significant metabolites identified in the 
pathways; the P-value is based on the enrichment analysis; FDR indicates false discovery 
rate; impact designates the pathway impact as determined by pathway topology 
analysis……………………………………………………………………………………...
……55 
Table 3. Display of the percent differences and p-values of metabolites that were 
determined to be significant in each comparison group. Each group listed is compared to 
the respective controls for each sex. A positive percent difference indicates an 
upregulation of the metabolite in the experimental 
group.……………………………………………………………………………...65 
 
 
 
 
 
  
  1 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1: INTRODUCTION TO NMR AND METABOLOMICS 
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1.0 Overview 
Metabolomics provides an effective method to study cellular activity [1]. This is 
accomplished by applying a systems biology approach to analysing the small molecule 
metabolites found in bio-fluid or tissue samples [2]. Studies can be designed to study 
specific body functions and organs, or general health. Metabolomics has been proven to 
be an effective method to use when studying normal and pathological brain function [3]. 
Multiple bio-fluid types have been involved in metabolomics studies of brain-related 
disorders and diseases.  
The most common bio-fluids used in these studies are blood, urine, and 
cerebrospinal fluid (CSF) [4,5]. While CSF provides the most direct link to cerebral 
functioning, it is the least accessible [6]; however, blood and urine are both accessible and 
valuable samples to use in researching the brain [7-9]. The metabolic profiles from these 
fluids are global, and as such, all of the various body systems will be represented in these 
fluids. Metabolic wastes are transported by the blood and filtered by the kidneys into 
urine. While not all metabolites are waste by-products, wastes do represent a large portion 
of the metabolome [10]. The degree to which waste by-products originating from a 
specific organ or body system are present in blood or urine will approximately reflect of 
energy consumption from the organ of interest. Therefore, as the brain consumes almost a 
quarter of the body’s total energy, the profile of blood and urine will contain a large 
amount of information filtered directly from the brain [11]. Also, as the brain controls 
much of the activity of the body, conditions affecting the brain may manifest throughout 
the body as various other metabolic alterations, which will compound the net metabolic 
flux measured in bio-fluids. Analysis of these fluids provide an accurate method of 
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tracking disease progression [12], drug metabolism [13], recovery from injury (traumatic 
brain injury, TBI) [14], and response to environmental factors [15,16], making 
metabolomics of bio-fluids a valid experimental technique for studying how an organism 
responds to a disease or other stimuli. 
Tissues may also be used in metabolomics studies [17]. Although they require 
additional processing steps, they offer a localized perspective on the metabolic response 
of specific tissues to pathophysiological stimuli [18]. As will be shown, this allows for the 
possibility to detect and analyze how psychological stressors can impact body systems. 
 This thesis will introduce the theoretical framework that supports and validates 
metabolomics research. Introductory theory will also be provided on NMR, an analytical 
technique frequently utilized to obtain the metabolic profiles in metabolomics. The 
metabolomics theory will then be applied and illustrated using two case-control rat model 
studies of ancestral prenatal maternal stress. One involves urine metabolomics, the other 
uses tissue metabolomics of liver homogenate.  
1.1 Systems Biology 
Before exploring metabolomics specifically, it is worthwhile to examine systems 
biology approaches in general, and the primary research modalities that fall under this 
umbrella. Systems biology refers loosely to any holistic approach of modelling the 
complexity of biological systems. It differs from traditional reductionist approaches to 
biology which sought to dissect organisms to the smallest level possible and study the 
parts of a system in isolation. Systems approaches aim to take all the molecular pieces 
and reintegrate them to understand how they interact and function within the context of a 
living system [19]. 
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Living systems are primarily governed by the activity of four classes of biological 
components:  genes, transcripts, proteins, and metabolites. The study of each class of 
molecule has developed into an independent field of research, and when the study of 
these components is approached from a systems perspective they are often referred to as 
the ‘omics’. As such, the study of these classes of molecules are referred to as genomics, 
transcriptomics, proteomics, and metabolomics. The modelling of a system generally 
involves generating a thorough accounting of all the components, and then attempting to 
organize them into a network of various biochemical pathways and activities that reflect 
normal function [20]. The pathways, networks, and profiles that are characteristic of 
healthy normal function can then be compared to networks and profiles obtained from 
abnormally functioning systems. This facilitates the targeting of specific molecular 
processes and networks that go awry or malfunction in response to various stimuli [21].  
Genomics, transcriptomics, and proteomics provide information about the 
structure of system. These methods describe the framework that constrains cellular 
function. Alternatively, metabolomics provides information on the dynamic functioning 
of the structures within a cell. Metabolites occupy a unique role as they serve as the 
building blocks for genes, transcripts, and proteins, as well as the substrates and by-
products of metabolic activity. They can also interact with genes, transcripts, and proteins 
as cofactors and regulators of reactions [22]. Metabolites are the limiting currency within 
a cell. Whether considering energy needs or the structural component requirements for 
the macromolecular genes and proteins, the necessary small molecule metabolites must be 
present in order for functioning to occur. While the traditional reductionist biology tends 
to describe the information flow within a cell in a linear way, starting with genes and 
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ending with metabolites, systems biology approaches aim to consolidate the components 
into a cohesive network of interactive biological machinery to understand the holistic 
function of a system. The parts of a cell are heavily interconnected, and detailed 
understanding a system functions requires an appreciation of the relationships between 
the different biological components.  
1.2 Metabolic Phenotype 
Of all the ‘omics’ methods, metabolomics provides the closest measure to 
phenotype [23,24]. The genome of an organism stays essentially constant throughout a 
lifespan and a profile of all genes gives an idea of what is possible, not necessarily what is 
predetermined to happen. The environment interacts with the genome to control gene 
expression and determine phenotype, which is dynamic throughout a person’s life [25]. 
An illustration of how phenotype changes throughout the lifespan can be given by 
considering how a person changes as they age. An individual, from infant to elder, 
possesses the same genome throughout their life. Through varying which genes are 
expressed, they are able to grow, develop, and change as they age. Therefore, in contrast 
to the static genome, the expression of the genome, or phenotype, is capable of 
alterations. This process is mainly controlled by epigenomic regulation [26]. The 
flexibility of phenotype throughout life results in various proteins being built through 
different stages of life, as well as in response to environmental cues or disease. When 
different proteins are expressed, cellular function changes, resulting in a varied utilization 
of available metabolites and ultimately in distinct metabolic profiles reflective of the 
current phenotypical state. 
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  The metabolic by-products of an organism reflect the cellular processes that are 
currently at work [27]. Metabolism is the downstream terminal of the information 
pipeline that starts with genes and proceeds to protein synthesis and function; therefore, 
the metabolic profiles will reflect all upstream gene expression and protein function. 
Beyond this, metabolism also explains many short term effects caused by ingested toxins 
or drugs that involve a drastic change in cellular function, but no change in gene 
expression [1]. This is an additional reason why, of all the ‘omics’, metabolomics is able 
to most accurately explain and describe phenotype. 
 Research has been conducted to verify that metabolic phenotypes are consistent 
in healthy individuals [28], lending validity to the concept of using a metabolic phenotype 
as a reliable measure to monitor health. Additionally, diseases are accompanied by 
changes in metabolism [27]. Some studies have even suggested that detectable metabolic 
changes precede the expression of clinical symptoms of disease [29]. Therefore, there is 
credible scientific evidence lending support to the efforts pursuing metabolomic screening 
procedures capable not only of diagnosis, but also early detection of disease. While this 
has not yet been developed and implemented in a clinical setting, the practicality of it 
exists and this concept drives a large portion of health related metabolomic research. 
1.3 Metabolomics  
The goal of metabolomics is to provide a detailed account of the metabolic milieu 
that accompanies cellular activity [30]. Properly applied, this approach has the ability to 
determine interactions and activity of up-stream genes and proteins, as well as effects 
caused by environmental factors. Chemical analysis of samples is combined with 
multivariate statistical analysis to isolate the metabolites that vary significantly in a 
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meaningful way with the experimental outcomes. Pathway analysis can then be 
performed to identify molecular processes that are being affected by stimuli. 
Metabolomics has successfully been applied to a variety of research areas such as systems 
biology, drug discovery, disease detection, toxicology, food science, and more [31].  
The infancy of the field combined with the broad spectrum of applications 
translates into there currently being no standardization of the way to conduct these 
experiments and analyse the data. An initiative has begun that aims to provide standards 
of experimental practice that will aid in maintaining the integrity of information in 
metabolomics, which will increase the validity and consistency of inter-laboratory results 
[32]. However, there are no standardized protocols that are unanimously accepted by 
researchers. Some suggest that this is ideal, as methods are constantly being improved 
[33]. Further complicating the lack of precise protocols, there are multiple approaches to 
take in the research. One example of this is collecting the data. Presently, there are two 
dominating analytical platforms to use, either mass spectrometry (MS) or nuclear 
magnetic resonance spectroscopy (NMR). Both techniques are highly informative and 
offer advantages the other lacks. As the work in this thesis focuses on NMR 
metabolomics, a brief history of the development of NMR will be explored. A classical 
description of NMR theory will also be given for the purpose of understanding the 
theoretical basis of the applicability of NMR to metabolomics. Following the discussion 
of NMR, an outline of the most common standard practices in metabolomics will be 
discussed in the following sections. 
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2.0 Nuclear Magnetic Resonance Spectroscopy 
2.0.1 Historical Findings in Magnetic Resonance 
The theoretical and experimental groundwork that evolved into modern NMR 
spectroscopy began in the 1890’s. It is worth reviewing some of the milestone discoveries 
that led up to NMR, as the logical progression of the experiments aid in explaining the 
theory of magnetic resonance.  
Pieter Zeeman, in 1896, wanted to study what effect magnetism could have on 
visible light. To do this, he placed flaming sodium in an electromagnet and captured two 
emission spectra from the sodium; one with the magnet turned on and the other with it 
off. He noticed that with the magnet off the spectrum had more narrow lines than when 
the magnet was on. Later, using cadmium as light source with higher resolution, he 
determined that what first appeared as a broadening of the spectral lines was actually the 
lines splitting. The splitting of the emission lines is now referred to as the Zeeman effect 
or Zeeman splitting [34]. The explanation of why the splitting occurred would not come 
for another thirty years when the atomic property of spin was characterized. Zeeman was 
a co-recipient of the 1902 Nobel Prize in Physics along with Hendrik Lorentz. 
 In 1922, Otto Stern and Walter Gerlach were experimenting with concepts of 
quantum mechanics at a time when the quantum theory was new and the idea of mass, 
energy, and charge existing in discrete quantities was viewed with scepticism. They were 
attempting to test a hypothesis set forth by Neils Bohr and Arnold Sommerfeld 
concerning quantization of electron orbitals. Their experiment involved the production of 
a beam of silver atoms that was passed through slits to collimate the rays (make them 
parallel so as to have minimal spread during propagation) [35]. The collimated beam of 
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silver atoms was then passed through a magnetic field. From classical models, the 
expected result was that the particles passed through the magnetic field would form a 
continuous random pattern. The quantum model predicted that the particles would cluster 
in discrete groupings. Unsurprisingly to modern scientists, the result was that expected 
from the quantum model. This discrete grouping of the silver atoms was due to the spin 
angular momentum of the unpaired electron in the silver atom interacting with the 
magnetic field. This property of spin is the same property responsible for the Zeeman 
splitting. Stern received the Nobel Prize in Physics in 1943 for his continued work in 
measuring the quantized spin of the proton.  
A few years later in 1925 a major breakthrough in quantum theory came with the 
formalization of the concept of spin. As Wolfgang Pauli was contemplating the splitting 
of spectral lines observed by Zeeman he proposed that electrons possessed a “classically 
indescribably two valuedness” [36,37]. This statement means that the electrons seemed to 
possess the ability to be in either of two states, and that this quality was not accounted for 
by classical physics. This “two valuedness” is now referred to as spin, or spin angular 
momentum, and is a fundamental property of matter that is central to the NMR 
experiment. Though Pauli described the spin of electrons and used it to solidify his theory 
on the exclusion principle, the same property of spin is possessed by protons and 
neutrons, and just as the property of atomic mass and charge in atoms are a summation of 
the masses and charges of the protons and neutrons, so too does atomic spin exist as the 
net sum of spins of the constituent protons and neutrons. 
To this point, it had been discovered that magnetic fields could force atomic 
particles to assume orientations that were quantized, or limited to discrete values. Isidor 
  11 
Rabi focused on manipulating the particles to make transitions between the different 
quantum levels.  He accomplished this by applying an oscillating magnetic field to 
particles being passed through a static magnetic field. He found that when the energy of 
the oscillating field matched that of the energy difference between the quantized states 
that he could alter the orientation of the particles and have them transition to the other 
energy state. This effect is referred to as magnetic resonance and is a core component of 
the NMR experiment. The Nobel Prize in Physics in 1944 was awarded to Isidor Rabi for 
his work on magnetic resonance. 
The magnetic resonance effect, first observed in beams of particles by Rabi, was 
put to test in bulk matter by Felix Bloch and Edward Purcell. They worked independently 
of each other, but both discovered magnetic resonance effects, Bloch in water and Purcell 
in wax, at almost the same time. The methods employed were similar to those used by 
Rabi, namely that the sample was placed in a strong external magnetic field and a 
transverse oscillating magnetic field was applied. However, instead of being able to use a 
screen to detect deflection of particles, they needed more discrete methods of 
measurement. Purcell anticipated a change in the conductance of the wax and detected 
this using an electrical circuit [38]. Bloch arranged an electric coil to detect any 
electromagnetic radiation that would be emitted from the sample as a result of having the 
oscillating magnetic field applied [39]. Both detection methods worked and both proved 
that the magnetic resonance effect could be applied to bulk matter. Bloch and Purcell 
were joint recipients of the 1952 Nobel Prize in Physics. 
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2.1 Current NMR Theory 
2.1.1 Properties of Subatomic Particles 
Following these discoveries, it was understood that the innate magnetization of 
matter could be manipulated and monitored using strong magnets and precise electronics. 
These theories matured into the modern fields of NMR and MRI. Here we will provide a 
basic description of classical NMR theory and the NMR experiment, a more detailed 
description can be found in a number of NMR textbooks [40-42]. The majority of NMR 
experiments deal in some way with the hydrogen atom, and it is the hydrogen atoms of a 
sample that are the focus of most NMR metabonomic experiments; therefore, they will 
serve as the prototypical nuclei to explain NMR. Hydrogen atoms possess only a single 
proton in the nucleus, and as such are often referred to simply as protons in NMR jargon. 
Protons and neutrons, sometimes referred to collectively as nucleons, constitute the 
nucleus of atoms and possess certain intrinsic properties that are the basic units used to 
describe matter. The properties under consideration, and which are fundamental to 
producing the magnetic resonance effect, are mass, charge, and spin. 
2.1.2 Mass and Charge 
 
That protons and neutrons have a mass is easily understood, as mass is present in 
the macroscopic world. The mass of any substance, at an elementary level, is the net sum 
of the masses of the nucleons. Likewise, nucleons also possess a charge. The charge of a 
proton is +1 and the charge of a neutron is 0. The net charge of a nucleus is the net sum of 
the charges of all the constituent protons and neutrons. Therefore, the proton’s charge is 
just +1. At a macroscopic level the positive charge of a nucleus is generally cancelled out 
by the negative charge of the electrons, making the net charge of the object 0. This is 
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obviously not always the case, as charge imbalances are the principle behind voltage, the 
driving force of electric currents. However, in the average desk for example, the charges 
of the nucleus and electrons will cancel.  
2.1.3 Spin 
The other intrinsic property of nucleons is spin. Spin is difficult to conceptualize 
because it does not have a macroscopically observable presence. It is important to 
remember that spin is a fundamental aspect of the building blocks of matter and cannot be 
described as a product of mass or charge, it exists independent of the other properties and 
causes the atom of particles to behave as if they were spinning. Protons, neutrons, 
electrons, and most of the other subatomic particles have spin. In physics terms, spin is a 
vector because it has both a magnitude and a direction. In matter outside of a magnetic 
field the spins align randomly, have a single energy level, and produce a net spin vector 
of zero. In a magnetic field, the spins will experience Zeeman splitting and separate into 
2I+1 different energy levels, where I is the value of the atom’s spin. A proton is spin ½, 
therefore energy states of protons in a magnetic separate into 2 energy levels. These two 
energy levels are analogous to the splitting of atoms into distinct groups by Stern and 
Gerlach and the broadening of spectral lines by Zeeman.  
2.1.4 Magnetism 
From classical mechanics, it is shown that a rotating mass will have an angular 
momentum vector that points along the axis of rotation. Classical mechanics also 
provides the information that a moving electric charge will produce a magnetic field. 
These two concepts are manifested at the atomic level. From the explanation of intrinsic 
properties, it is known that a nucleus will have a mass, charge, and spin. The spinning 
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character of the nucleus acts on the mass to produce an angular momentum vector (J) and 
works on the charge to produce a magnetic moment (μ). The nucleus of an atom can be 
characterized by the angular momentum and the magnetic moment using a value called 
the gyromagnetic ration (γ). The relationship between J, μ, and γ is given in equation 1, 
where q is the charge of the nucleus and m is the mass. 
Equation 1. γ =
μ
J
=
q
2m
 
This equation is a simplified way to view the calculation of γ, and is presented this way to 
illustrate how γ depends on the magnetic moment and angular momentum of a nucleus, or 
in more fundamental terms, the mass and charge of a nucleus. Since for any element, the 
nucleus of different atoms are identical, the γ will be identical for all atoms of the same 
element. Therefore, all protons will have a γ = 42.5 MHz/T. Gyromagnetic ratios are 
normally presented in units of rad s-1 T-1, but the MHz/T units represent a more user 
friendly representation of the data. The value of γ determines some of the behaviour of 
the nucleus when placed in a magnetic field 
 Magnets interact with each other in a predictable manner through their magnet 
fields. Applied to NMR, the small magnetic moments of the individual nuclei will interact 
with any magnetic field they are placed in. The force of interaction will be proportional to 
the size of the magnetic field vectors being considered. Atomic magnetic moments do 
interact with the earth’s magnetic field, although it is a very weak interaction as the 
earth’s magnetic field is relatively weak. Nuclei cannot have their magnet fields 
amplified; however, the field they are placed in can be augmented to increase the strength 
of interaction. This process is enabled by NMR spectrometers. At the heart of every 
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spectrometer is an electromagnet that produces a field which can be up to 100 000 times 
stronger than earth’s field. The magnet needs to be strong enough to interact with the tiny 
atomic magnetic moments and thereby induce a polarization in the sample. As mentioned 
earlier, the nuclear spins align randomly in matter. When placed in a magnetic field, the 
spins begin to precess in an organized manner. The precession is caused by the torque 
resulting from the interaction of the magnetic moment with the magnetic field of the 
magnet (Bo). Shown in equation 2, μ and Bo have a vector product (torque, τ) which will 
be perpendicular to the two vectors. This perpendicular nature of the torque produces a 
perpetual spinning motion called precession. 
Equation 2. τ = μ x Bo 
The precession can be compared to a spinning top, with the top’s angular 
momentum being analogous to the magnetic moment and the earth’s gravitational field 
being analogous to the static magnetic field of the spectrometer. As the top is spinning in 
the gravitational field it begins a slow precession as long as the angular momentum is not 
directly aligned with the gravitational field. If the angular momentum were perfectly 
aligned with the gravitational field, there would be stable rotation (no perpendicular 
torque) as the cross product of parallel vectors is zero. This analogy offers a visualization 
of what precessional motion looks like. The rate at which precession occurs is referred to 
as the Larmour frequency (ω), and is determined by multiplying the γ for the nuclei by 
Bo. 
Equation 3. ω = γ Bo 
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The spins all precess around the axis of Bo and this oriented motion produces a net 
magnetic moment that points in the same direction as Bo, which is defined as the positive 
z-axis. This is not to say that all the spins align in the same direction along the field. 
Before the field is introduced, the spins are randomly aligned with a no net magnetization. 
As the field is introduced, the spins being to precess around the field, and this uniform 
precession creates a net magnetization that points along the direction of Bo (Figure 1). 
This is a total net magnetization, and is composed of a net magnetization pointing parallel 
to the field (α) and another net magnetization pointing in opposite direction (β) as shown 
in Figure 1. The more energetically favourable orientation is that aligned parallel to the 
field, as such it is larger and the total net magnetization always points parallel to Bo. 
However, the energy difference between the two states tends to be quite small and the 
population difference is small as well. As the field strength is increased it becomes more 
energetically favourable to be in the α state, as such, the population of spins in the α state 
increases, the difference in energy between α and β states increases, and the net 
magnetization vector increases. This widening of the energy difference between α and β 
with an increase in magnetic field strength is a manifestation of the Zeeman Effect 
(Figure 2).  
 
 
 
Figure 1. Illustration of the net magnetization being composed of parallel and anti-
parallel components, with Bo pointing along the positive z-axis. 
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Figure 2. Illustration of Zeeman splitting with formulas correlating the Larmour 
frequency to the energy difference between the two energy levels. 
Population differences between α and β states are also affected by temperature. If 
the temperature is increased, there is a greater amount of energy available to the spins and 
the unfavourableness of the anti-parallel state is diminished. Conversely, as the 
temperature of the sample is lowered, the anti-parallel state becomes even more 
energetically unfavourable, the parallel state becomes more populated, and the net 
magnetization of the sample increases. Increases in the net magnetization will in turn 
increase the strength of the signal obtained during experimentation. The determinants of 
population difference, and therefore net magnetization of the sample, are summarized in 
equation 4. 
Equation 4. 
Pα
Pβ
= ekT
 γB
 
Where Pα is the population of spins parallel to the field, Pβ is the population of spins anti-
parallel to the field, B is the strength of the static magnetic field, T is the temperature in 
the Kelvin scale, γ is the gyromagnetic ratio, and k is the Boltzmann constant.  
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The work done by Rabi, Bloch, and Purcell showed that the bulk magnetization of 
a sample could be manipulated by applying an oscillating electromagnetic pulse. The 
energy of the pulse must match the energy difference between the α and β spin states, 
which corresponds to the Larmour frequency. These pulses are referred to as on 
resonance pulses. Again, this energy difference will depend on the value of γ, or in other 
words the type of nucleus, and the strength of Bo as in equation 2. This energy difference 
corresponds to electromagnetic radiation from the radio frequency (RF) range of the 
spectrum, as such the applied field is often referred to as an RF pulse. Equation 5 shows 
the relations ship between the frequency of electromagnetic radiation and energy. 
Equation 5. E = hν (h is Planck’s constant and ν is the frequency of the RF pulse) 
2.1.5 Detecting the NMR Signal 
When simply precessing about the z-axis, there is no way to measure the 
frequency of the bulk magnetization. This is because NMR measures the changes in 
magnetization over time. At equilibrium, the vector is precessing symmetrically around 
the z-axis, leading the transverse component of the magnetization to average to 0 over 
time. The application of the RF pulse occurs perpendicular to the z-axis in the x, y plane, 
which is also referred to as the transverse plane. This pulse is generated using an RF coil 
and applied at a frequency that is on resonance with the nuclear spins of interest; more 
importantly. It has the effect to force the net magnetization from the z-axis into the 
transverse plane where it continues to precess around Bo. The physics behind the pulse 
tipping the magnetization is similar to the torque causing precession. Except instead of a 
single magnetic moment being caused to precess, the bulk magnetization experiences a 
torque that forces it into the transverse plane. It is the transverse magnetization that serves 
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as the source of the NMR signal. Once in the transverse plane, the net magnetization will 
“relax” back to equilibrium, much as a bobo doll returns upright after being struck. This 
occurs in an asymmetrical manner, leading to a magnetization vector that does not 
average to 0 over time, and is therefore detectable. There are two forms of relaxation that 
govern the return to equilibrium relaxation. Transverse, or T2 relaxation is a measure of 
how long it takes for the transverse magnetization signal to diminish. Longitudinal, or T1 
relaxation is a measure of how long it takes for the net magnetization to rebuild along the 
z-axis. These two processes are both on the order of seconds, with the transverse 
magnetization typically diminishing faster than the longitudinal magnetization rebuilds.  
Pulse sequence is the name given to the structured array of RF pulses applied to a 
sample before the resulting signal is acquired. The Simplest version of a pulse sequence is 
the pulse-acquire experiment (described above) in which a 90-degree RF pulse is applied 
and is immediately followed by acquisition. The longer a pulse is applied for, the farther 
the magnetization will be tipped, and it is not uncommon for one pulse sequence to 
incorporate multiple pulses with multiple tip angles in order to manipulate the 
magnetization to give very specific information. Different pulse sequences are designed 
to give specific information about the molecules in a sample. Basic experiments are 
designed to inform on the structural connectivity of functional groups within a molecule. 
More complex experiments can give information regarding the interaction of two atoms 
of the same element, interaction of two atoms of different elements, and the distance 
between atoms in the molecule, to name a few. Other pulse sequences can be designed to 
remove, or suppress, undesirable signals. The pulse sequences are constrained in duration 
by the relaxation rates of the nuclei within the sample. As soon as a sample is irradiated 
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with an RF pulse, it instantly begins to re-establish equilibrium magnetization along the z-
axis. Therefore, a pulse sequence needs to be able to apply all the necessary RF pulses 
fast enough to still have net magnetization present in the transverse plane to detect.  
The NMR signal is detected during the relaxation process. The RF pulse does not 
change the Larmour frequency of the protons, it only forces the magnetization into the 
transverse plane to be detected. The frequency is detected using the same electric coil that 
delivered the RF pulse. The principle of reciprocity states that the ability of a substance to 
deliver an electric current is proportional to its capacity to have an electric current 
induced in it. The RF pulse is delivered through an electric coil. Since all electric currents 
emanate a magnetic field, it is the magnetic field produced by sending a current through 
the coil that generates the RF energy that tips the net magnetization. Once in the 
transverse plane, the precessing magnetization has the ability to induce a current in the 
coil. This is exactly what happens. Magnetization in the transverse plane induces an 
electric current in the coil as it moves to equilibrium. This analogue current is the 
detected NMR signal and it is digitized using an analogue-to-digital converter (ADC). 
The resulting digital NMR signal is then sent to a computer for processing.  
 The raw data from an NMR experiments is called the free induction decay (FID), 
and represents the sum of all the precessional frequencies of the sample in the time 
domain. Figure 3 illustrates the FID for a single frequency. In this case, it would be a 
relatively simple task to measure the period of the time signal and calculate the 
frequency. However, real data is much more complex and represents hundreds of 
overlapping frequencies, as shown in Figure 4. In this case, calculating the period of each 
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time signal is nearly impossible by hand and a computer algorithm that employs a 
specialized mathematical function is used to determine the resonance frequencies. 
 
Figure 3. FID of a singfrequency and the resulting FT. 
 
Figure 4. FID of real data and the resulting FT showing a portion of the spectrum. 
The mathematical function used by the computer to determine the frequencies in 
the FID is called a Fourier Transform (FT), named after the French mathematician Jean-
Baptiste Joseph Fourier who developed the theory around 1811. The FT is the practical 
FT 
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implementation of the Fourier Relationship, which explains how the time domain is 
related to frequency domain. Simply put, when a FT is applied to a signal in the time 
domain, or the FID, the result will be a signal in the frequency domain, known as a 
spectrum. 
When the FID is acquired it is a time domain signal that represents the precession 
of the bulk magnetization in the transverse plane. As the signal returns to equilibrium, the 
amplitude of the FID is seen to diminish, but the wavelength, or frequency, remains 
constant over time. By applying a FT to the FID the signal is converted to a frequency 
domain. Once represented as frequencies, the information is much simpler to interpret, 
and this is how NMR data is most often presented.  
2.1.6 Chemical Shift 
In a basic proton NMR experiment the only type of nucleus being observed is 
hydrogen. Since all protons have the same γ and during the experiment they are all in the 
same strength of magnetic field, one would expect from equation 3 that all the protons in 
the sample would precess at the same frequency and would therefore result in a single 
resonance peak in the spectrum. This is not the case, and in even a relatively simple 
spectrum of a single molecule there can be many peaks. This is because the magnetic 
field that is experienced by each of the protons is not just Bo, but is actually Bo plus the 
tiny magnetic fields generated by the circulating electrons in the molecule. Electrons tend 
to have the effect to oppose Bo, effectively lowering the magnitude of the external 
magnetic field experiences; therefore, the more electrons crowding a proton, the lower its 
frequency will be (an effect called shielding), and the fewer electrons crowding a proton 
the higher its frequency will be (an effect called deshielding). This is shown in equation 
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6. It is because of these minutely different localized magnetic fields that different 
frequencies are observed for a single type of atom. To give an idea of how small the 
divergences are, the differences in local magnetic fields of chemically different nuclei are 
on the order of 1-10 millionths of the magnitude of the static magnetic field strength Bo In 
NMR, the frequency of each spectral line is known as the chemical shift, and is affected 
by the local electronic environment of the nuclei. There is a high degree of consistency in 
what amount of shielding is caused by different functional groups. This knowledge has 
been applied to help identify structural elements of molecules using NMR. 
Equation 6. ω = γ Blocal where Blocal = Bo – Beletrons 
Frequencies of chemical shifts in an NMR spectrum are given in parts per million 
(ppm) as shown in equation 6. The reference frequency is a frequency that is assigned to 
be zero ppm. Generally, that frequency is the resonance frequency of protons in 
trimethylsilane (TMS). In metabonomics, the solvent used is water, TMS is not water 
soluble; therefore, water soluble trimethylsilylpropionic acid (TSP) or 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS) are most often used instead. TSP and DSS have almost 
identical chemical shifts to TMS and are used as the 0 ppm reference point. A major 
advantage to using the ppm scale to represent chemical shifts is that as the magnetic field 
of new spectrometers increases the actual resonant frequency of the nuclei, the relative 
chemical shift in ppm does not change.  
Equation 7. δ (ppm) = 
νref−ν
νref
  
(νref is the Larmour frequency of the reference compound (TMS, DSS, or TSP) and will 
be at 0ppm. 
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The strength of an NMR magnetic field is often quoted as the Larmour frequency 
of a proton in that magnetic field. Therefore, a magnet with a strength of 7.04 Tesla 
would be referred to as a 300 MHz magnet as the protons would rotate 300 million times 
each second in that magnetic field. This value of 300 MHz is obtained by multiplying the 
magnetic field strength by the γ for proton as in equation 3. Similarly, a magnet with a 
field strength of 16.4 Tesla would be referred to as a 700 MHz magnet because the 
protons would be rotating 700 million times each second.  
2.1.7 J-Coupling 
In the NMR world, magnet manufacturers have constantly been pushing to 
develop more powerful magnets. This may seem an unimportant advancement as the 
chemical shift of the signals will not change. What does change, and why increased 
magnet strength is important, is that the overall obtained signal intensity is greater 
(equation 4) and the number of Hz within each part per million is increased. This has the 
effect of spreading out the chemical shift of each signal. Inspection of an NMR spectrum 
will show that there is often some sort of multiplet structure. These multiplets retain the 
splitting pattern and splitting distance in Hz with an increasing Bo field strength. This 
means that as the chemical shifts separate further with increasing Bo, the splitting of each 
signal will remain constant, leading to a more easily interpreted spectrum. This is well 
illustrated in the proton spectrum of arginine acquired at 300 and 700 MHz (Figure 5 and 
6, respectively).  At 300 MHz there appears to be a single multiplet structure at the far 
right of the spectrum and this is shown to be two clearly separate multiplet signals at 700 
MHz. This is because the two multiplet signals are overlapping at 300 MHz and the 
increased magnetic field at 700 MHz has allowed for the separation of these two signals. 
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Interestingly, the two triplets at the left of the spectra do not appear to change between the 
two different magnetic field strengths; furthermore, if the splitting of these triplets were 
measured, they would be the same in both spectra. This is just one illustration of many 
demonstrating the increased ability to analyze a spectrum that comes with an increase in 
magnet strength. 
Figure 5. Arginine proton spectrum at 300MHz. 
Figure 6. Arginine proton spectrum at 700MHz. 
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The multiplet structure gives information regarding the connectivity of the 
molecule. This is because each proton, or unique peak in the spectrum experiences a 
small magnetic field from adjacent non-equivalent proton spins, as each spin is essentially 
a little bar magnet. These small magnetic fields cause the single peak to be split into 
2*N*I +1 lines, where N is the number of non-equivalent proton nuclei adjacent to nuclei 
and I is the spin of the nuclei. For Protons where I=1/2 this equation simply becomes 
N+1. Thus, if you have no proton neighbors (N=0) you will get a single peak (singlet), if 
you have 1 non-equivalent proton neighbor (N=1) you will get 2 peaks (doublet), and so 
on and so forth. The intensity of each peak in the multiplet pattern follows the rules of 
Pascals' Triangle. This coupling to neighboring nonequivalent protons is known as J-
coupling and is a much smaller effect than the shielding or deshielding, as it is given in 
Hz; furthermore, as mentioned above, the splitting observed due to J-coupling is 
independent of the magnetic field strength.  
 When the signal is received as an FID, all of the information about chemical shift 
and coupling is in the FID. Upon FT of the data, the frequency information is easily 
interpreted and the structure and connectivity of the molecule being studied can be 
determined. The magnitude of signal coming from each peak in the spectrum is 
proportional to the number of spins contributing to that signal in the sample. Integration 
of a peak in the spectrum is a way of measuring this magnitude and, in a sample of a 
single compound, will correspond to the number of protons making that signal. From this, 
peaks in an NMR spectrum from methyl protons are easily distinguished from peaks 
arising from methylene or methine protons as the integration values will scale as 3, 2, and 
1 respectively. In metabolomic samples containing multiple molecules, the integration 
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values of the different peaks can be adapted to be used as a measure of relative 
concentration, as a more concentrated molecule will produce more signal and therefore a 
larger integral than a less concentrated molecule. If a peak is split into a multiplet 
structure, the entire multiplet must be integrated to obtain an accurate value. 
2.1.8 Receiver Gain 
In order to acquire all the information from the FID the spectrometer’s electronics 
must be calibrated properly. One value that changes frequently is the receiver gain of the 
analogue-to-digital converter (ADC). The receiver gain is adjusted to be able to detect the 
entire strongest signal in the spectrum. In metabolomics this is problematic as the sample 
is almost entirely water at about 55M. The dissolved metabolites will constitute only a 
small portion of the NMR signal, with concentrations in the mili- to micromolar range. 
The problem arises because when the signal is acquired it must be digitized. An effect of 
the digitization can be visualized as follows. Consider the NMR peak to be a certain 
height, say two feet. Upon digitization, these two feet are segmented into a defined 
number of equally spaced pieces, like ticks on a ruler or measuring tape. If the two feet 
were to be segmented into only eight pieces, the rest of the signals would be defined as 
being values corresponding to one of those eight segments. If a signal were to be too 
small to be taller than the first segment (less than 3 inches in this example) then the signal 
would not be visible in the spectrum. The reason the water signal is problematic in 
metabolomics is that it is literally thousands of times stronger than the metabolite signals. 
This means that once the receiver gain is set to accommodate the massive water signal, 
there is a loss of sensitivity to the lower concentration signals. The spectrometers digitize 
  28 
into much more than eight pieces, but if nothing is done to the water signal there is a large 
portion of information lost due to the decreased sensitivity.  
Modern pulse sequences are able to manipulate the net magnetization in such a 
way that the signal from the water is almost completely removed. The benefit in this is 
that the sensitivity of the digitization to the low level metabolites is increased. Back to the 
two-foot signal example, each segment of digitization with the two-foot signal is three 
inches. If that signal is removed and the next largest signal is only one inch, then 
segmentation into eight pieces leaves a digitizer that is sensitive to within an eighth of an 
inch. Again, the actual method of how this happens is more sophisticated and involves 
more knowledge of electronics, but the analogy of how removal of the water signal 
improves sensitivity to low concentration metabolites is valid.  
2.2 Metabolomics Methods 
This section will discuss metabolomics methods and procedures in the order that 
an experiment is conducted. A normal experiment would first have the sample collected 
and stored, the sample would then be prepared for experimentation and the data collected. 
Following this is statistical analysis and interpretation of the results. With this workflow 
in mind, sample collection recommendations will first be discussed. Following this, the 
strengths, weaknesses, and preparation methods of the most common sample types will be 
discussed. This will be followed by a comparison of NMR and MS for data collection. 
The last section will be on the various statistical approaches that are often adopted in 
metabolomics. As the focus of this thesis is NMR metabolomics, the discussion will focus 
on NMR, with exception to the section comparing NMR to MS.  
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2.2.1 Sample Collection and Storage 
Sample collection protocols will vary depending on the type of sample being 
analysed and the procedures followed by a particular lab [43]. Regardless of the sample 
type, there are necessary precautions that must be taken to ensure that once the sample 
has left the organism the integrity of the metabolic profile is maintained [44]. The profile 
is most often affected by bacterial digestion of the metabolites. A common way to protect 
the metabolites from this is to immediately freeze the sample once it is collected. 
Normally stored at -80°C, a review of storage procedures indicated that -25°C is 
sufficient to halt the breakdown of metabolites due to bacterial activity [44]. Others 
recommend adding an antimicrobial agent to the sample prior to storage. Once stored 
properly, the samples may be good indefinitely, but at least for a six months as indicated 
by a study on the topic. On occasion, samples will end up being thawed and refrozen prior 
to metabolomics analysis. Although not encouraged, in the event this does happen, the 
freeze thaw cycle will not significantly impact the results [44]. When the time does come 
to prepare the sample, most sample types have similar preparation procedures.  
2.3 Sample Types and Preparation 
A major strength of NMR is that almost any bio-fluid can be used and sample 
preparation for analysis is simple. When preparing the samples, one thing that remains 
consistent is the need to combine the bio-fluid with a buffer solution, this also applies to 
tissue samples [43,45]. The buffer generally contains D2O, sodium azide, a chemical shift 
reference, and buffer salts. D2O, sometimes called heavy water, is structurally similar to 
normal water, but instead of two hydrogen atoms, there are two deuterium atoms in the 
molecule. Deuterium, like hydrogen, has a single proton in the nucleus. Unlike hydrogen, 
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deuterium also has a neutron. The presence of this neutron changes the γ of the nuclei 
resulting in D2O having a different precessional frequency than water and not appearing 
in a proton spectrum. There is still an NMR signal from D2O, and it is used to monitor the 
magnetic field of the spectrometer. All electromagnets experience minor fluctuations, or 
drift, that minutely alter the strength of the magnetic field over time. The spectrometer 
continuously analyzes the signal from D2O and uses additional magnet coils to make 
adjustments to the spectrometer’s magnetic field and keep D2O at the same frequency. 
This allows the spectrometer to maintain the same net field strength and correct for the 
drift in the magnetic field during an experiment. Sodium azide is added as an 
antimicrobial agent in order to prevent any bacteria that may be present from digesting 
the metabolites. The chemical shift reference is necessary to properly assign the chemical 
shifts in the spectrum and was discussed in section 2.1.6. While blood and CSF are 
physiologically constrained to a narrow pH range, urine has a broad range of normal 
possibilities. This can be problematic as many metabolites have chemical shifts that are 
pH dependent, making it is necessary to adjust all the samples to have a uniform pH by 
using the buffer salts. 
  Common bio-fluids that get studied are urine [23], blood [46], CSF [6], saliva 
[47], breath condensate [48], amniotic fluid [49], and breast milk [50]. When trying to 
determine which fluid is best suited to a particular study, it should be remembered that 
bio-fluids offer complimentary information. For example, urine will contain metabolites 
that are filtered out of the blood, while the blood will contain the unfiltered metabolites. 
For this reason, it is worthwhile to combine information from multiple sample types to 
increase the power of a study. The fluids that have received the most attention and 
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therefore are the most characterized are urine, blood, and CSF. The use of these three 
fluid types, as well as the use of tissues, will be explored.  
2.3.1 Urine 
Urine is the produced as the kidneys filter wastes and excess materials from the 
blood and concentrate them in the bladder. This collection and concentration translates 
into multiple benefits to analysing urine. One is that the sample is concentrated enough to 
give excellent signal in a small amount of experiment time. After filtration through the 
kidneys, samples are also relatively free of large macromolecules that tend to obstruct the 
spectra, and any cellular debris that may be present is easily removed following 
centrifugation during sample preparation. Another benefit is that the urinary metabolic 
profile gives a global perspective of the waste products from the entire body. Considering 
that almost a quarter of human energy consumption is from the brain the waste products 
from the brain will be highly represented in the urinary profile. Urine is also one of the 
least invasive samples to obtain from a subject, making the implementation of this type of 
research in a clinical setting realistic for researchers and stress free for patients. 
 Importantly, Profiles from urine do exhibit diurnal fluctuations [51]. Most studies 
collect samples either as the first pass of the day after a night of fasting, or as a one-day 
average of multiple samples from a single person to avoid this innate variation in urinary 
profiles.  
Diet also impacts the urinary metabolic profile [52,53]. Some researchers 
implement a diet normalization in their subjects for one day prior to sample collection in 
order to minimize dietary fluctuations all study participants are fed the exact same diet for 
that day [54]. Results indicate that this indeed helps to mitigate some of the individual 
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variation normally seen in human studies. Other factors that have been shown to impact 
the urinary metabolic profile are age, sex, and ethnicity [51]. Even with these sources of 
variation, urine has also been shown to maintain a stable representative phenotype in 
healthy controls [55,56], making it a valid medium for tracking disease development and 
progression.  
Preparation of urine for an NMR experiment is incredibly simple. The sample 
needs only be combined with the proper buffer, centrifuged, and transferred to an NMR 
tube for experimentation.   
2.3.2 Blood 
Blood is essentially the highway down which many metabolites, wastes, and other 
materials travel from one place in the body to another. Using similar logic as with urine, 
since the brain is such a large consumer of resources in the body, a large portion of the 
blood is always in the brain and large portion of by-products in the blood will be from the 
brain. Both blood plasma and serum are regularly used for metabolomics analysis. 
Temporally, it exhibits less diurnal variation than urine, leading some to prefer it over the 
use of urine [57]. Blood also contains fewer detectable metabolites and consequently is 
more simple to analyze than urine [46].  
One complicating factor that does exist with blood is that it has a high protein and 
fat content [58]. This adds unwanted signals to the spectrum and obstructs low 
concentration metabolites. The macromolecules can be left in the sample, but they are 
generally considered to detract from the information present. The signals from these 
molecules tend to be very broad and are reminiscent of a large hill blocking the view of a 
skyline. The chemical shift reference TSP also binds to the macromolecules [43]. This 
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will result in erroneous quantification if the TSP is to be used for concentration 
calculations during analysis. For this reason, many blood metabolomics studies use an 
alternate reference material such as formate. If the macromolecules are removed, TSP 
again becomes a suitable reference molecule. There are different ways of removing the 
signal from the proteins and fats, which will essentially create an unobstructed skyline 
view of the spectrum.    
The three most common approaches to removing the macromolecular signals are 
to adjust the NMR pulse sequence to remove the signal from these molecules [59], 
physically remove the molecules using a filter [60], or to precipitate the proteins and fats 
using a chemical extraction [61]. The most common pulse sequence used to remove these 
broad signals is a Car-Purcell-Meiboom-Gill (CPMG). It works well to make the 
spectrum appear less obstructed. However, a side effect of this experiment is signals from 
the metabolites are also attenuated. This happens because the CPMG experiment exploits 
the different relaxation rates of small and large molecules. As mentioned previously, the 
NMR signal is detected in the time period between application of the RF pulse and the net 
magnetization returning to equilibrium. Not all nuclei relax at the same rate, and in 
general, signals from large molecules will relax faster than signals from small molecules. 
The CPMG pule sequence is relatively long, and through a series of pulse manipulations, 
the signals from large molecules are removed. During this time though, signals from 
smaller molecules have time to diminish as well. The appeal to this method is there are no 
additional preprocessing steps or alterations made to the sample. However, the signals 
from fast relaxing metabolites will be less, or even gone if this pulse sequence is used.  
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Filtering works well to physically remove the macromolecules from each sample. 
This approach has been shown to be highly reproducible, but it is a costly in both time 
and money. Alternatively, a variety of different precipitation techniques, all using 
common chemicals, can be performed for little money. To do this, a blood sample is 
typically combined with a chemical such as methanol, perchloric acid, or acetonitrile. 
After a short incubation period, the mixture is centrifuged and the pellet removed, leaving 
behind a sample free of macromolecules. A recent review recommended using methanol 
to perform the extraction [61]; however, each method of removing these molecules has 
strengths and weaknesses that vary greatly. Also, each method does not detect signals 
from all metabolites to the same degree. This makes it important to study the effects of 
the different sample pre-treatment protocols to pick the method best suited to recovering 
the information of most worth to the experiment.  
Once the decision is made on whether or not the macromolecules will be removed, 
the blood is mixed with a buffer. If the fats and proteins are removed, the same buffer as 
for urine can be used. If the macromolecules are left behind, a modified buffer must be 
used which incorporates an alternate chemical shift reference. Some groups simply mix 
blood with a saline solution, instead of a buffered solution, as blood is self buffering in 
the body to approximately pH 7.35-7.4. Again, similar to urine, the use of blood is 
translatable to a clinical setting as the collection of blood samples for a number of assays 
are already common.  
2.3.3 Cerebrospinal Fluid 
CSF provides a more localized metabolic profile. Contained within the central 
nervous system, it reflects brain functioning more closely than blood or urine. CSF 
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contains fewer metabolites than urine, making it more simple to analyze and attempts are 
being made at automating its analysis [60]. CSF can be collected at will in animal models; 
however, in a clinical setting it is much more challenging to obtain a sample without great 
need for it. This makes CSF a more challenging sample type to translate to clinical work. 
Just like blood and urine, NMR analysis of CSF requires only that it be mixed with the 
buffer and centrifuged prior to experimentation.  
2.3.4 Solid Tissue 
Tissues provide the most localized and specific metabolic profile. There are three 
primary ways of analyzing tissue for metabolomics. One is to excise and homogenize the 
tissue, then extract the metabolites [18]. This typically gives the best resolution of 
metabolites in the spectrum from NMR of tissue samples. Another method is called high 
resolution magic angle spinning (HR MAS), which uses intact tissue in a solid state 
spectrometer [62]. Solid state spectroscopy is arguably more complicated than solution 
work and the spectral resolution tends to be lower than with homogenized tissues. 
However, by using intact tissues, it reduces the variation of the data caused by the lab 
procedures required to homogenize tissue. Lastly, an MRI can be used to perform a 
procedure known as magnetic resonance spectroscopy (MRS). This process involves 
collecting a standard one dimensional proton spectrum from a single voxel in the MRI 
data [63]. An obvious strength of this technique is that it is non-invasive and leaves the 
tissue intact in a living organism. It does suffer from poor spectral resolution, and requires 
an MRI, which are less accessible than NMR spectrometers.   
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2.4 Experimental Platforms 
The primary analytical techniques used in metabolomics are NMR and MS. There 
will be a brief summary of the two techniques, followed by a comparison of the relative 
strengths and weaknesses of the techniques. 
2.4.1 Nuclear Magnetic Resonance Protocols 
As discussed in the beginning of this chapter, NMR spectroscopy works by 
manipulating the minute magnetic fields that exist at the nuclei of atoms. This is 
accomplished by first aligning all the nuclei using a strong magnetic field. Within this 
field, the minute magnetic fields of the nuclei precess, or ‘spin’. The rate of precession is 
product of the strength of the spectrometers magnetic field and the nuclei’s charge and 
mass; therefore, atoms of different elements will have different precessional frequencies. 
Although NMR experiments can be conducted on many different types of nuclei, the most 
common in metabolomics is hydrogen (1H) because it is so abundant in biological 
molecules. The NMR experiments require that a transverse magnetic field is applied to 
the sample to disrupt the nuclei from their equilibrium state along the magnetic field 
lines. This transverse magnetization is applied at the same frequency as the nuclei’s 
precession. Because the pulse to disrupt the nuclei needs to be on resonance with the 
nuclei of interest, the spectrum is usually free from interference from nuclei of other 
elements in the sample. As the nuclei return to equilibrium, their magnetic field induces 
an electric current in the circuitry of the spectrometer. This is the origin of the NMR 
signal. The signal is composed of the net current produced by the nuclei and is 
proportional to the total number of nuclei in the sample. Each metabolite in a sample will 
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contribute a unique signal to the spectrum. In metabolomics, these signals are compared 
to a library of pure substances to determine what compounds are present in the sample.  
2.4.2 Mass Spectrometry Approaches 
Mass spectrometry works by breaking a molecule into ionized fragments and 
measuring the mass to charge ratio of those fragments. On a basic level, every mass 
spectrometer has three main parts: a source where ions are formed, an analyzer that 
separates the ions based on the mass to charge ratio, and a detector that produces a signal 
each time an ion contacts it. The first step is to ionize the sample, which can be done in a 
number of different ways [64]. Ions are then accelerated through a vacuum while various 
magnetic and electric fields are applied in order to separate the ions by their mass to 
charge ration. The kinetic energy of the particles determines how they are deflected in the 
analyzer. The separated ions are electrostatically propelled into the detector and can now 
be detected as discrete mass fragments [65]. MS is routinely used to determine the exact 
mass of a molecule and can help to determine the structure of molecules. Similar to 
NMR, when used in metabolomics, MS spectra are compared to spectra of pure 
compounds to determine what metabolites are present. It is standard practice to separate 
the sample based on some chemical property to improve the resolution of the results. The 
most common separation techniques are liquid chromatography and gas chromatography. 
By introducing the separation, it is typically necessary to run multiple experiments for a 
single sample in order to analyze all the different fractions from the separation [31].  
2.4.3 Technological Comparisons 
Considering the brief overview of how the primary analytical techniques of 
metabolomics function, their respective strengths will now be highlighted. The most 
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notable differences between the techniques are how the samples are prepared, the 
reproducibility of the experiments, how quantitative the results are, recovery of the 
sample after experimentation, the sensitivity or minimum concentration for detection, 
number of experiments required, and the time and money to perform the experiments. A 
more thorough exploration of the comparisons between techniques is available from a 
number of reviews [22,30,31] 
2.4.4 Sample Preparation 
With regard to NMR, minimal treatment of samples is necessary before analysis. 
For fluid samples, the preparation is as simple as combining the bio-fluid with a buffer 
and transferring the mixture to an NMR tube, ready for the spectrometer. Additional to 
the buffer salts, the solution generally has D2O to provide a locking frequency signal for 
the spectrometer, sodium azide or some other antimicrobial agent to prevent the 
metabolites in the sample from being metabolized by bacteria, and a chemical shift 
reference indicator such as DSS or TSP. The chemical reference compound can also 
double as reference for concentration measurements of all other metabolites in the 
sample. Contrastingly, MS typically requires chemical extractions or derivatization to 
separate each sample into multiple fractions based on pKa, hydrophobicity, or other 
chemical properties. This need to separate the sample leads less reliable experiment 
reproducibility. 
2.4.5 Reproducibility of Results 
The simple preparation protocol of samples for the NMR experiment aides in the 
results being exceptionally reproducible. As mentioned, in typical biofluid NMR 
metabolomics there are no chemical reactions prior to analysis, reducing the possibility of 
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experimenter error affecting the results. As more steps are added to any experiment the 
opportunity for experimenter error and differential results is introduced. Since MS can be 
a multi-step process, involving extraction and ionization of metabolites, it is inherently 
less reproducible than NMR analysis and results are less consistent. 
2.4.6 Quantitative Analysis 
The nature of the NMR signal makes quantification very simple. The signa l 
derives from protons in the sample that interact with the magnetic fields of the 
spectrometer. The signal obtained is proportional to the number of protons producing that 
signal. The signals in the spectrum can then be measured and compared to either a known 
reference compound that is added to the sample or to an electronic reference spectrum to 
calculate the concentration of known compounds in the spectrum [66]. Determination of 
the correct concentration requires that the identity of the signal is known. Theoretically 
simple, it is quite difficult and labour intensive to implement quantitation. This is 
evidenced by the large number of qualitative NMR metabolomics studies compared to 
quantitative studies [54]. Quantitation of mass spectra is more complicated and requires 
an internal standard in the sample for each metabolite to be quantified [22]. The addition 
of these specific internal standards becomes quite expensive and labour intensive.  
2.4.7 Non-Destructive Procedures 
The MS experiment requires that the sample be ionized (fragmented into pieces) 
in order to analyzed, which eliminates the chance of reusing the sample for future uses. 
Conversely, NMR requires no such destruction of the sample and the sample integrity is 
maintained throughout the experiment. However, MS experiments require micromolar 
volumes, whereas NMR experiments typically use about half a millilitre of sample. The 
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need for large volumes in NMR makes some research, such as rodent model urine or CSF 
obtained via microdialysis, difficult to perform.  
2.4.8 Sensitivity 
The largest strength that MS has over NMR is that it is a much more sensitive 
technique. With a room temperature probe, NMR can detect metabolite concentrations in 
the low millimolar range, while MS is orders of magnitude more sensitive with a lower 
detection limit in the nanomolar range. NMR sensitivity can be increased in a number of 
ways. A cryo-probe can be used to reduce thermal noise in the NMR signal, this 
decreases the noise, thereby increasing the signal. Microcoil probes can also be used, 
which are probes designed to use a smaller amount of sample as well as to have a more 
sensitive detection ability. The NMR experiment can be also run for a longer period of 
time. A typical NMR experiment takes only a few seconds to perform a single scan, but to 
get informative results the experiment is repeated multiple times and the results are 
combined into a single spectrum. The relationship between signal and noise when 
summating multiple repeats of the same experiment is that the signal increases as a 
function of root N, where N is equal to the number of scans. Therefore, to get twice the 
signal to noise, the experiment time must be quadrupled. There are obvious diminishing 
returns with trying to increase sensitivity this way and it is impractical to expect to obtain 
the same sensitivity in NMR as in MS just by extending the experiment. Another way to 
increase the signal to noise and sensitivity is to increase the strength of the NMR magnet. 
This has the effect to increase the number of nuclei in the α state, thereby increasing the 
net magnetization vector of the sample. The different techniques mentioned can also be 
combined to increase the NMR signal even more.  
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Related to the sensitivity, MS can also detect many more metabolites in a sample, 
primarily because it detects metabolites that are below the detection limit of NMR. The 
typical NMR metabolomic sample can anticipate to identify between 40-100 metabolites 
in a sample, whereas MS experiments detect over 500. Incidentally, an MS spectrum has 
far more unknown compounds in them than an NMR spectrum. 
2.4.9 Single-Step Analysis Procedures 
NMR experiments are able to collect information of all metabolites at once. In 
urine metabolomics, almost all metabolites are water soluble and present together in the 
sample; therefore, only a single experiment is necessary to obtain all the metabolite 
information. With tissues and blood analysis, the sample can be separated into water 
soluble and fat soluble fractions, which would then require two experiments to obtain all 
the information. Mass spectrometry samples that undergo a separation will typically 
require multiple different fractions to be analysed separately. The fractions are generally 
separated on the basis of various chemical properties of the metabolites, and the property 
determining the separation will change with the separation technique used. There are 
multiple chromatography techniques that can be used to separate the different classes of 
metabolites [64]. Acquisition of a comprehensive metabolite profile will require that more 
than one method be used [20,65]. This is because the chemical properties, such as pKa or 
polarity, of metabolites cover a wide range, and no single separation method (liquid 
chromatography, gas chromotography) will separate all metabolites. Additionally, no one 
detector can measure all metabolites because the dynamic range of the detector is less 
than the concentration ranges of metabolites in biological samples. These factors lead to 
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MS needing many more separate experiments to be run in order to obtain all the 
information from a single sample. 
2.4.10 Time Considerations 
Preparation of a sample for NMR takes less time than MS. Once in the machine, 
NMR experiments can take as little as 5 to ten minutes to acquire a spectrum. MS can 
take longer, and with the need to run multiple experiments on a single sample to get the 
full complement of metabolites present, MS takes much longer than NMR when coupled 
with popular LC/GC-MS techniques. 
2.4.11 Cost Effectiveness 
Given that analysis of a sample by MS requires separation prior to analysis and 
multiple standards for quantification, it is not surprising that MS costs more money per 
sample than NMR. Although the cost of the experiments is not often seen in reviews, it is 
worthwhile to note that labs offering to perform metabolomics for a price will perform 
analysis by NMR for a fraction of the price of MS. When evaluating the quality of 
information versus the cost of the experiment, NMR is a more valuable per dollar 
technique. 
2.5 Data Analysis  
2.5.1 Profiling Approach 
Analysis of metabolomics data can be divided into two main streams, profiling 
and targeted analysis [22]. Although many of the steps involved with these two 
approaches are extremely similar, they offer fundamentally different ways of looking at 
the data, and answer different types of research questions. Profiling, sometimes called 
untargeted or chemometric studies, is done when there is limited information available 
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about a topic and proposing an explicit scientific hypothesis is not feasible [67]. There is 
the general hypothesis that condition A and B will exhibit distinct metabolic profiles, but 
no specifics are given as to what metabolites are expected to change with the 
experimental conditions. The goal of these studies are to acquire valid quantitative or 
qualitative measures of as wide a range of metabolites as possible with the intent of being 
able to distill the results into something meaningful that can then be re-tested and verified 
in the future. Qualitative or chemometric approaches are often considered to be 
hypothesis generating for this reason. During analysis, the whole profile can be used as a 
classification tool to separate cases from controls, or significant features can be identified 
and proposed as potential bio-markers for the condition under study. Since the entire 
profile is being used, these studies regularly return significant features that are not 
currently identifiable. 
2.5.2 Targeted Analysis 
Alternatively, targeted approaches require that all metabolites involved in analysis 
are accurately quantified [54,68,69]. This method selects a subset of metabolites that are 
anticipated to have been effected by the experimental conditions and focuses the analysis 
on them. Usually, only the subset will be quantified and statistically analyzed.  
2.5.3 Binning 
Whether a targeted or profiling approach is adopted, the sample preparation and 
data acquisition for NMR is the same. Data processing and statistica l analysis also 
remains somewhat similar. If the metabolites are to be quantified, there are various 
software packages available that are capable of this, with the final output being a matrix 
of the concentrations of metabolites found in each sample [60,70]. If quantification is 
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unavailable, then qualitative methods are used. This begins with segmenting the spectra 
into a discrete number of bins [71]. This serves to reduce the size of the data set. NMR 
spectra are collected as a set of hundreds of thousands of data points. Working with data 
this large would be unnecessarily time consuming and require large amounts of computer 
processing power. Binning reduces these hundreds of thousands of points down to 100-
400 discrete spectral segments referred to as buckets or bins. The bins can be all of the 
same width across the entire spectrum or adapted to precisely include metabolite signals 
(Figure 7). Adapting the bins is time consuming, but usually provides a more accurate 
representation of the data. Bins of equal width are prone to splitting peaks in half or 
putting the same metabolite from different spectra in different bins if the data sets are not 
aligned perfectly. Each bin is qualitatively represented as the integral of the spectrum 
within the bin boundary. This translates approximately into the relative concentration of 
the metabolite within the bin, but not the actual concentration value. 
 
Figure 7. A region of multiple spectra stacked on top of each other and binned to include 
entire signals in a single bin. 
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2.5.4 Normalization 
  Once the spectra are binned, there are a number of data transformations that can 
applied. If it is a targeted study, these transformations can be applied to the concentration 
values. It is standard to apply a normalization method to each spectrum and a scaling 
function to each bin. Normalization can be to a reference spectrum, total spectrum area, 
or to a reference feature [72]. The importance of normalization is best expressed by 
giving an example. In urine metabolomics, samples from many different subjects are 
compared. If one person normally passes more water in their urine than another, their 
sample will appear to be much more dilute, even if they both subjects have the same total 
metabolite content present in their sample. To generalize this idea, by normalizing the 
data, individual differences in the dilution of metabolites are adjusted for. Hence, the 
variation in the relative amounts of metabolite present is more prominent [73]. Generally, 
the region of the spectrum corresponding to water is removed prior to normalization to 
remove effects of imperfect removal of the water signal.   
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Figure 8. Illustration of spectra being binned and the dimensions that normalization and 
scaling work it. Normalization functions on each individual spectrum, while scaling 
functions on a bin single bin across all the spectra. 
2.5.5 Scaling 
Scaling helps to offset the tendency for metabolites of higher concentration to 
dominate the results [74]. Major differences between concentrations and variances of 
different metabolites tend to force most multivariate statistical techniques to focus on the 
most intense signals, ignoring valuable information that is potentially held in the smaller 
signals. By scaling the data, this effect can be mitigated or removed, depending on the 
choice of scaling function that is applied. One common method of scaling is called unit 
variance, or auto scaling, which sets the mean of each metabolite to zero and the standard 
deviation to 1. The formula for unit variance is given in equation 7 and its effect is to 
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weight all metabolites the same, completely removing issues related to disparate 
concentrations. Another method often employed is Pareto scaling. In Pareto scaling the 
mean is also adjusted to be zero, and the data is then divided by the square root of the 
standard deviation as shown in equation 8. Pareto scaling retains a greater similarity to 
the original data structure than with auto scaling. Both methods help to increase the 
visibility of variation in low concentration metabolites. This is important because the 
concentrations of metabolites cover a range of values that vary by several orders of 
magnitude. By scaling, low concentration data is not lost [75]. 
Equation 8. Auto Scaling = 
x average−x bin
SD
 
Equation 9. Pareto Scaling = 
x average−x bin
√SD 
 
2.5.6 Multivariate Statistics 
After the data is normalized and scaled, it is analysed using multivariate statistical 
tests. The large number of variables, or bins, in metabolomic data sets leads to difficulty 
in identifying patterns because graphical representation of samples composed 100+ 
variables is not possible. Luckily, multiple tests exist that offer a way to visualize and 
interpret the data. Principal component analysis (PCA) is most often the first test used 
because it expresses the data in a way that highlights differences and similarities between 
the samples and aids in pattern identification [76,77]. Importantly, it is an unsupervised 
technique, meaning that the statistical analysis does not involve designating which group 
a sample belongs to and there is no possibility to over-fit the data or conclude that non-
existent patterns are real. PCA takes all the variables and calculates new principal 
components, which mathematically are the product of the original dataset and the 
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eigenvectors of the covariance matrix of the data [78]. Graphing of the components 
provides the scores plot, in which each data point represents a single sample, and points 
that group together have more similar characteristics than points that are distant. As the 
data size is reduced, some information is lost; however, the percent of the total variance 
explained by a principal component can be calculated, and when two or three components 
are used to make a graph, the total variance explained by the graph is the sum of the 
variance explained by each component. It is not uncommon to have a data set with 
hundreds of variables have more than 60% of the total information of the data explained 
by two principal components. Studies that want to determine if metabolic profiles can be 
used to discriminate between two groups perform PCA in order to visualize if their 
experimental groups cluster separately in the scores plot.  
Generally, if PCA shows separation, partial least squares discriminant analysis 
(PLS-DA) is then used. PLS-DA is similar to PCA in that it is a clustering algorithm that 
reduces the dimensional space of a data set [79]. However, it is a supervised technique, 
meaning that the group identity of the samples is given [80]. As an aside, if in the formula 
each sample is defined as an independent group, the PLS-DA scores will be identical to 
PCA scores. The value of PLS-DA is that it specifically maximizes the differences 
between groups, as opposed to exposing differences between all the samples. Due to the 
supervision of the grouping the results are potentially more informative for answering the 
research question; however, it is prone to over-fit the data and produce grouping that is 
not real [81]. This is why PCA is run first to see if the groups cluster independently 
without supervision. Even with prior PCA, PLS-DA is routinely couple with rigorous 
cross validation and permutation testing in order to validate the results [81,80].  A similar 
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approach to PLS-DA is orthogonal partial least squares discriminant analysis (OPLS-
DA). The predictive value of OPLS-DA has been shown to be the same as that for PLS-
DA [82]. The benefit of using this technique is that it places greatest variance in a single 
axis, which is accomplished simply by rotating the PLS-DA scores plot [83].    
2.5.7 Variable Selection 
The multi-variate techniques mentioned above are used in both profiling and 
targeted studies to determine class membership and see if there is an overall difference 
between the groups. Some studies end with this type of analysis and conclude that the 
whole profile can be used to classify samples into groups and no attempt is made to find a 
subset of metabolites that could function as biomarkers [84]. Most metabolomics studies 
go beyond saying simply that the samples cluster correctly between the groups, and 
identify metabolites that are predictive of group membership. There are a number of ways 
to determine which metabolites are important. The simplest method is to perform 
univariate hypothesis testing, such as a t-test of Mann-Whitney U test [85]. These will 
indicate which metabolites have an average that varies significantly between the cases 
and controls. A weakness of univariate statistics is that it has no way of accounting for 
synergetic and compounding effects caused by multiple metabolites interacting with each 
other.  Also, since multiple hypothesis tests are being conducted, p-values need to be 
corrected for multiple comparisons using methods such as Bonferoni correction in order 
to reduce the number of false discoveries [86]. Most experiments either stay away from 
univariate testing due to its lack of power, or combine it with some form of multivariate 
metabolite identification.  
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There are many multivariate methods that exist for determining the most 
important variables. Most commonly, PLS-DA coefficient weights or variable importance 
in the projection (VIP) values can be used to determine whether or not a metabolite is 
important [72]. With these methods, each variable has an associated value calculated for 
it and threshold value is decided as to what will be considered important or not. For VIP, 
it has been suggested that any value greater than 1 is enough to classify a variable as 
important, but this is not a rule [87]. In general, the coefficients and VIP will identify the 
same metabolites as being important.  
Receiver operator characteristic (ROC) curves can be used as a test for evaluating 
the predictive power of a small set of metabolites [88]. The worth of most current 
biomarkers is determined by the area under the curve (AUC) that they obtain. ROC 
curves plot the number of true positives against the number of false positives. The AUC is 
a measure of how accurate the model is at classifying cases and controls, with an AUC of 
1 being perfect classification and 0.5 being random chance. Applied to metabolomics, this 
test can be applied to demonstrate the strength of a proposed bio-marker [68].  
A new method has recently been developed called variable importance analysis 
based on random variable combination (VIAVC), which systematically resamples 
variables to determine if potentially synergetic effects exist between seemingly 
unimportant variables [89]. The algorithm combines random permutation of variables 
with a 10-fold cross validation (CV) of models to determine the optimal subset of 
variables that provide the most information about the differences between groups. With 
each random permutation of variables, an AUC for the ROC model is calculated and used 
as the measure of how good the metabolites are at predicting the class of the samples.  
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2.5.8 Pathway Analysis 
There is currently no accepted standard for the optimal method for analysing data. 
Even though this is the case, a recent study that used the same data in multiple labs found 
that consistent results for a metabolomic experiment were obtained in different labs using 
different processing techniques and different statistical analysis [90]. This finding is 
supported by the work done on this thesis. Several different metabolite selection 
techniques were used when analyzing the data, and it was found that in general, each 
method provided very similar results. So even though the methods of experimentation are 
not standardized, the results tend to be reliable and similar regardless off the differences 
in workflow.  
Once important metabolites are identified it is then possible to link them to 
functional pathways in an organism. Web based platforms exist that are capable of 
searching online databases of biochemical pathways and disease profiles in order to link 
the metabolites to possible functional origins [21,91]. This is valuable in adding context 
and meaning to results beyond a list of differential metabolites.   
2.6 Applications of NMR Metabolomics to Neuroscience 
NMR Metabolomics has experienced widespread applications in drug discovery, 
systems biology, pharmaceuticals, disease detection, and toxicology [31]. Part of what 
makes metabolomics so versatile in studying biological systems is the simplicity of the 
experimental preparation and the ability to analyse all components in a solution at once. 
With most living organisms being a salt bag, it is easy to take almost any biological 
sample and find a way to obtain a profile of all the small molecule metabolites. In studies 
of the brain, NMR metabolomics has been applied in a number of ways using the 
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different sample types discussed. An overview of some representative studies will be 
given that illustrate the power and applicability of NMR metabolomics to research of 
brain related diseases and disorders. The studies cover both rodent and human models that 
used blood, urine, CSF, or tissue for analysis.  
2.6.1 Animal Models using NMR Metabolomics 
Blood plasma from a rat model was used to evaluate the different stress models 
commonly used to induce depression like symptoms in rats. Three different stress 
paradigms were compared and all three types of stress had distinguishably different 
metabolic responses. Chronic unpredictable mild stress (CUMS) affected glutamate 
metabolism, energy metabolism, and inflammatory responses. The one day forced swim 
test group showed changes in metabolites affected by intestinal micro-organisms, and the 
fourteen day forced swim test group showed impacts to lipid metabolism. From this study 
the group concluded that metabolomics and clinical data supports CUMS as the most 
representative model of human depression that was studied [92]. This shows that 
metabolism is highly linked to the stress response of the animals, to the extent that 
different forms of stress were detectable in the metabolic profiles. This is important to 
understand as stress related disorders affect a large portion of the world’s population. 
 NMR metabolomics of urine from a mouse model of Alzheimer’s disease (AD) 
found markers of oxidative stress in urinary profiles prior to becoming symptomatic. The 
markers discovered were 3-hydroxykynurenine and homogentisate, which are both 
precursor molecules of reactive oxidizing species (ROS) [93]. ROS are involved in the 
pathogenesis of AD and this finding helps point to a potential biomarker that could be 
used to help early diagnosis of the disease. This would greatly improve the quality of life 
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of many people and families as early detection and therapies have been shown to slow the 
progression of the disease.  
Recently, a mouse model of closed head injury was used to study traumatic brain 
injury (TBI). Whole brains were homogenized and analyzed using quantitative 
metabolomics analysis. A ROC model was constructed using the concentrations of ADP, 
AMP, NAD+ and IMP which had perfect class discrimination. This model was validated 
using further statistical testing and proven to be significant. The analysis also revealed 
that TBI leads to disturbances in mitochondrial function, energy metabolism, and 
neurotransmitter function [94]. These are timely results as there is a growing concern over 
the side effects of mild TBI experienced by so many people, and further knowledge on 
this topic is being sought after.  
Using a mouse model of Batten’s disease, brain tissue from multiple brain regions 
was analyzed. Batten’s disease is a fatal autosomal recessive neurodegenerative disorder 
that typically begins in childhood. All regions studied showed a deficit in cycling of 
neurotransmitters indicated by imbalances of glutamate, glutamine, and GABA. These 
differences were detected at one month old, which is significant because neuronal loss 
characteristic of this disease does not typically begin for another six months in the mouse 
model of this disease [95]. 
How drugs affect brain metabolism has recently been explored in the brain 
homogenates of mice. Specifically, the metabolic response to diazepam in a anisatin-
induced convulsive seizure model in homogenized brain samples from specific brain 
regions. Diazepam is a benzodiazepine frequently prescribed as an anxiolytic and also as 
to treat seizures. Previous studies on diazepam have focussed on how it effects the amino 
  54 
butyrate system. This study was able to show that diazepam helps to recover damaged 
neurotransmitter metabolism as well as lessening oxidative stress, minimizing energy 
metabolism disturbances, and rebalancing amino acid metabolism. The results from the 
metabolomic experiment were integrated with histopathological and behavioural data to 
provide a more holistic understanding of the treatment effects of diazepam [96].  
2.6.2 Human Studies of NMR Metabolomics  
As informative as animal models are, human studies provide information that is so 
much more intimately connected to the concerns of society. The following studies all 
used human samples and again illustrate the diversity of applications of metabolomics 
and the wealth of information recovered from these studies. 
Major depressive disorder (MDD) is a pervasive mental health disorder with no 
empirical lab test to support its diagnosis. A study involving NMR metabolomics of blood 
plasma from drug naïve MDD patients was able to create an OPLS-DA model that 
successfully distinguished between MDD patients and controls, as well as accurately 
diagnosing blinded samples that were added to the model. The metabolites integral to the 
classification accuracy were involved in lipid and energy metabolism [97]. These results 
suggest the possibility of generating an empirical test to aid in the diagnoses MDD and 
potentially even develop and screening test for people at risk of developing this disease.   
Multiple sclerosis (MS) was investigated using plasma from human patients 
suffering from the disease. The study used PCA and OPLS-DA to create a model of the 
data and select metabolites important to discriminating between the MS and control 
samples. The metabolites that were selected are involved in tryptophan metabolism and 
energy metabolism. The ROC model created from the identified metabolites had almost 
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perfect class discrimination with an AUC of 0.98 when applied to a set of samples not 
included in building the model. The study pointed out that while the disease tends to have 
a heterogenous expression in the population, sometimes making clinical diagnosis quite 
difficult, the results from this study point to a very consistent alteration in energy 
metabolism, which could be utilized to increase the accuracy with which people are 
diagnosed with this disease [98].  
A recent review of urinary markers of brain disease illustrated that human urine 
has been largely ignored compared to other sample types when searching for markers of 
brain disease [7] Even with this, the limited studies on urinary based bio-marker of brain 
diseases that do exist indicate that urine has significant value when searching biomarkers 
of some brain diseases. The studies reviewed in this article provided some promising 
evidences, indicating that clinically applicable urine biomarkers of brain diseases may 
largely exist and should be useful in future diagnoses. If proven reliable, urinary 
biomarkers of brain diseases would be an informative and convenient tool with clinical 
applications. 
In another study of MDD, similar to the one using blood plasma, urine was 
analysed to determine its diagnostic power when separating classes from controls [99]. 
Multivariate analysis of the data yielded a panel of six candidate bio-markers of MDD. 
These six markers were included in an ROC model and yielded an AUC of more than 
0.917 when tested against samples not included in the model. This is another study 
showing the plausibility of developing a lab test for depression.  
 An investigation into the differences of urinary metabolic profiles associated with 
neuropathic and nociceptive pain was able to classify between the types of pain with high 
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specificity [100]. The classification required use of the entire metabolic fingerprint; 
however, specific metabolites were identified that suggested that neuropathic pain was 
accompanied by neuronal damage. This was evident by the metabolites that were key to 
the discrimination between groups. Information such as this is crucial when trying to 
determine the best course of action to take when treating different types of pain.  
Most people don’t hesitate too much to give a blood sample, and even fewer think 
twice about giving a urine sample. However, CSF sample collection is a painful and 
unpleasant experience, making it harder to get permission to obtain and consequently less 
accessible for experimental purposes. Even with these hindrances, there have been a 
number of studies analyzing human CSF.  
A study using CSF from over 152 participants was able to distinguish between 
drug naïve individuals with a recent diagnosis of schizophrenia and controls [101]. 
Interestingly, the study also showed that medication was able to return the metabolic 
profile to normal, but only if the disease had been caught and medicated early. This 
emphasizes the need for an early detection and treatment of the disease. Beyond being 
able to classify the different groups in the experiment, the results also showed that brain 
specific alterations to glucoregulatory activity in the brain are part of the pathogenesis of 
schizophrenia. 
Using human CSF samples again, PD patients and healthy controls were able 
classified separately with high fidelity [102]. The primary metabolites that were altered 
between groups were involved in glucose metabolism. It is encouraging that the results of 
this study correspond with other research on PD. 
  57 
As mentioned earlier, there are a number of elements that can be analysed using 
NMR. This study used carbon instead of hydrogen. The researchers used labelled carbon 
and were able to determine which metabolic pathway is used for energy production in the 
brain following TBI [103]. CSF was collected from the brains of participants using a 
microdialysis pump. These samples indicated that following injury the amount of 
anaerobic glucose metabolism in the brain increases and that this increase is achieved 
through activation of the pentose phosphate metabolic pathway of energy metabolism.  
Using CSF 1H-NMR metabolomics and unsupervised statistical methods, distinct 
differences in the metabolic profiles of MS and non-MS control patients were observed 
[104]. The metabolites that varied significantly between the groups were involved in 
energy metabolism and phospholipid metabolism. The study did have a small sample size, 
but provides reasonable grounds to continue research targeted at developing a metabolic 
biomarker of MS.  
In a 2015 study, ALS patients had their CSF compared to that of healthy controls 
using NMR metabolomics. The results pointed towards ALS being partially characterized 
by a hyper-catabolic state with evidence that this state could possibly involve 
mitochondrial function [12]. The team proposed ethanol as a putative biomarker for 
neuronal tissue damage in ALS. 
Brain tissue samples in rodent models have provided incredible information 
regarding the pathogenesis of various condition, and it would be nice to have similar 
studies in humans, but there are obvious barriers to excising brain tissue from people just 
for experiments. Much more common is to utilize MRS, which allows in-vivo analysis of 
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metabolic profiles by using an MRI. There is at least one study; however, that was able to 
obtain human brain samples for analysis.  
In 2014, the metabolome of post mortem brain tissue from AD patients was 
analyzed. The results showed that AD brain tissue revealed dysregulation of taurine and 
hypotaurine metabolism, as well as alanine, aspartate, and glutamate metabolism [105]. 
The metabolite concentrations were fair (ROC AUC = 0.67) at discriminating cases from 
controls; however, by comparing pairs of metabolites ratios, opposed to absolute 
concentrations, a more powerful discrimination was achieved.   
Entirely non-invasive, MRS uses an MRI instead of a NMR spectrometer. It 
should be noted that the use of MRS instead of NMR does come with a cost, as the 
resolution of metabolites is greatly reduced when compared to NMR spectroscopy. An 
MRS study of concussion tracked the progression and recovery of metabolic fluctuations 
following injury [106]. The soonest analysis after a concussion occurred 3 days post 
injury for all subjects. This time frame exhibited the largest deviation from baseline of the 
metabolic profile. The profiles were seen to normalize of the course of a 30 days, with a 
normal profile being obtained on day 30. This study provides information that could help 
guide sports medicine doctors on when an appropriate time to return to sport would be 
following an injury. Another MRS study measured the concentration of NAA in relation 
to cerebral vasculopathy [107]. The results indicated that NAA was reduced in this 
condition.   
2.6.3 Discussion 
NMR metabolomics is an adaptable technique that can be applied to a wide range 
of experimental designs. It provides significant and often novel insights into metabolic 
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responses to various stimuli. The results are often meaningful on their own, leading to the 
increasing popularity of this branch of systems biology [24,108]. Metabolism is also 
considered to provide the closest measure to phenotype, giving the study of metabolic 
profiles great value for use monitoring and measuring the health of an organism 
[109,110]. The ability to analyze all metabolites present in a single experiment offers the 
possibility of developing an extensive screening test that could replace a battery of assays 
and tests with a single experiment. This is a reasonable goal to work towards as diseases 
are often accompanied by altered metabolism [27] and metabolic changes precede disease 
symptoms in some cases [29] leading to the possibility of screening for early detection 
and treatment of disease.   
Beyond simply using one sample type in a study, results from multiple bio-fluids 
or sample locations can provide a wider perspective on the dynamic response to diseases 
[31,111-115]. NMR metabolomics can also be combined with MS metabolomics to 
harness the strengths of both techniques and identify previously unknown metabolites 
[116]. Other systems biology approaches have been combined with metabolomics so that 
information on both the structure and dynamic functioning of the system is obtained in a 
single study [117]. Metabolomics testing has also been applied alongside existing clinical 
methods [118] to increase the sensitivity of current diagnostic tests. 
The synergetic combination of omics data has potential to vastly improve 
personalize medicine. By combining omics platforms, it opens the possibility to consider 
complex interactions within the individual. Metabolomics potentially offers a key in 
determining why drugs affect people differently, which is a major hurdle in modern 
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medicine. Indeed, there are some toxicological effects, such as drunkenness, that can only 
be explained by metabolomics [1].  
The potential for metabolomics to help answer questions in neurological [119], 
and psychiatric [120] disorders has been explored in recent reviews. These reviews, and 
others, illustrate the fundamental link between brain diseases and metabolism [121], and 
suggest the possibility of exploiting this connection to develop therapies [122].  
An instigator of many mental health disorders is stress [123,124]. Chronic stress 
has been shown to precipitate the development of several diseases and negative symptoms 
such as depression, anxiety, decreased cognitive abilities, and erratic behaviours [125]. 
Additionally, stress experienced by pregnant mothers has been shown to cause a ripple of 
effects through multiple subsequent generations [126]. The metabolic effects of ancestral 
prenatal maternal stress have not received much focus. Chapter two of this thesis will 
analyze how prenatal maternal stress effects the urinary metabolic profile of F4 male 
offspring, and chapter three will also analyze the effects of prenatal maternal stress, this 
time in the liver metabolic profile of F4 male and female offspring.   
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3.0 Introduction 
Mental health disorders are the leading cause of disability worldwide. A recent 
survey of representative communities from 28 countries conducted by the World Health 
Organization (WHO) World Mental Health initiative found the prevalence of mental 
health disorders to be up to 36% in the population [127]. Among these, anxiety was the 
most common condition, followed by mood disorders, externalizing disorders, such as 
attention deficit hyperactive disorder and oppositional defiant disorder, and substance 
abuse disorders [127]. Although these disorders differ in their symptoms, all of them are 
commonly influenced by the experience of stress or exposure to an adverse environment 
[123,128]. Treatments for these disorders are often ineffective and the lack of 
understanding concerning their etiology is hindering the ability to develop more effective 
cures. 
Lifetime stress experienced by the individual has long been considered as a 
possible cause for mental health disorders. Additionally, recent discoveries have 
emphasized that stress experienced by the mother during pregnancy can impact the 
developing fetal brain and increase the probability of the offspring developing mental 
illness [129-131]. Support for this argument comes from human cohort studies of 
individuals whose mothers were pregnant during a traumatic event or natural disaster 
[132,133]. Results from these studies showed that maternal exposure to adversity during 
pregnancy was associated with accelerated cognitive decline in later life [134], higher 
lifetime incidences of schizophrenia [135], poor cognitive health [136,137], altered 
immune function [138], and unique DNA-methylation signatures [139]. Other studies on 
prenatal stress during human development support a link between the mother’s mood 
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during pregnancy and increased risk of attention deficit hyperactive disorder, anxiety, and 
cognitive impairment [140]. Experimental studies have isolated the influence of prenatal 
stress (PS) on higher lifetime incidence of altered stress response, anxiety, reduced 
attention, learning deficits [140] and that these changes may propagate to subsequent 
generations [141-143]. 
Recent studies have documented that an early adverse environment affects more 
than one generation of offspring [142-144]. For example, human studies involving the 
Dutch Famine Birth Cohort have suggested that prenatal undernutrition can significantly 
affect the health of children (F1) and grand-children (F2) [145]. Experimental data have 
shown that prenatal exposure to toxins [144,146,147] and stress [142] alter behaviour and 
stress response across several generations (F1-F3). Long-term outcomes include altered 
affective state and physiology [131,141-143,148] and the development of new 
behavioural traits based on multigenerational stress programming in the F4 generation 
[149-151]. Potential mechanisms of transgenerational programming involve variations in 
maternal care [152,153], epigenetic regulation by DNA methylation [130,139] and 
microRNAs [142,143]. 
Metabolic profiles reflect cellular functioning; therefore, up-stream epigenetically 
regulated gene and protein expression will be detectable in metabolic profiles 
[1,4,30,109,110]. Clearly identifiable metabolic signatures linked to mental health 
disorders have been identified using 1H nuclear magnetic resonance (NMR) spectroscopy 
[99,101]. Connecting altered epigenetic states, due to PS, to functional pathways reveals 
that its neurodevelopmental consequences are linked to altered brain [5,154,155] and 
amniotic fluid [156] metabolic signatures. Here we used 1H NMR spectroscopy to 
determine if epigenetic programming caused by a single exposure to experimental PS four 
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generations removed permanently alters metabolic activity. In addition, we identified 
clearly distinguishable metabolic fingerprints in urine to discriminate the consequences  
of multigenerational versus transgenerational prenatal stress in the filial F4 
generation (Figure 1). These metabolic profiles were used to determine metabolic 
pathways that are implicated in mental health disorders. These findings are an important 
demonstration that ancestral origins of altered mental health can be indicated by 
metabolic signatures that are of clinical predictive and diagnostic value. 
3.1 Materials and Methods 
3.1.1 Animals 
This study involved Long-Evans rats raised at the Canadian Centre for 
Behavioural Neuroscience, University of Lethbridge vivarium. The animals were housed 
in pairs under a 12:12 h light/dark cycle with light starting at 07:30 h and the room 
temperature set at 22 °C. Rat chow food and water were available at libitum. All 
procedures were approved by the University of Lethbridge Animal Care Committee in 
compliance with the guidelines of the Canadian Council on Animal Care. 
3.1.2 Experimental Design 
To investigate unambiguous transgenerational programming of an adult metabolic 
phenotype [40], this study focuses on six-month old males from the F4 generation. The 
use of males minimized the potential impact of female hormonal fluctuations [157]. Four 
successive generations of timed-pregnant female rats were bred under consistent 
laboratory conditions. Parental female rats (F0) were exposed to stress during pregnancy. 
For the multigenerational stress lineage (F4-SSSS; n=6) the pregnant daughters (F1), 
granddaughters (F2), and great granddaughters (F3) were also stressed during pregnancy. 
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The transgenerational stress lineage (F4-SNNN; n=6) was bred by stressing only the F0 
mothers and not the F1 – F3 mothers (see Figure 1; S = stress, N = non-stress condition). 
Yolked controls were bred in parallel for each generation (Control, n=7). 
  
Figure 9. Illustration of the experimental design that tested the F4 offspring of a lineage 
in which stress occurred in each generation (multigenerational stress, SSSS) or in which 
stress was limited to the first parental generation (transgenerational stress, SNNN. 
3.1.3 Stress Procedure 
Pregnant dams were subjected to stress daily from gestational day (GD) 12 to GD 
18. This timeframe was used as it corresponds to the third trimester in human pregnancy 
when substantial neural development occurs [158]. Stressors included restraint in a 
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Plexiglas cylinder for 20 min and forced swimming in warm water at 21°C for 5 min. 
Stressors were administered each day in a semi-random alternating order; in the morning 
between 8:00-9:00 hours or in the afternoon between 16:00-17:00 hours. 
3.1.4 Behavioural Testing 
Open field locomotor activity was used to measure the exploratory behaviour, 
which serves as a standard parameter in the assessment of stress-induced emotional state 
[150,159]. Animals were placed individually into Accuscan activity monitoring Plexiglas 
boxes (length 42 cm, width 42 cm, height 30cm) and recorded for 10 min. The boxes 
attached to the computer recorded the activity based on sensor beam breaks. The 
horizontal beam breaks were recorded on the computer with the VersaMax™ program 
and converted to spread sheets using VersaDat™ software (AccuScan Instruments Inc., 
OH, USA). Distance traveled in the center of the open field arena was averaged to obtain 
the total distance traveled (in cm) per minute.  
3.1.5 Sample Collection and Preparation 
Subjects for analysis were euthanized with an injection of Euthanosol (Merck, 
QC, Canada) and perfused transcardially with phosphate-buffered saline (approximately 
200 ml) followed by a transcardial injection of approximately 200 ml of 4% 
paraformaldahyde (Sigma-Aldrich, MO, USA). Urine samples were obtained via bladder 
puncture with a 1.5 ml sterile syringe at time of euthanization and stored at -80oC. To 
prepare the samples for NMR spectroscopy, urine samples were thawed at room 
temperature and 450 μl aliquots were transferred into 1.5 ml centrifuge tubes with 250 μl 
of phosphate buffer. The phosphate buffer was prepared as a 4:1 ratio of 
KH2PO4:K2HPO4 in a 4:1 H2O:D2O solution to a final concentration of 0.5 M. The D2O 
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came with 0.05 % by weight trimethylsilyl propanoic acid (TSP) as a chemical shift 
reference. To protect the metabolite profile integrity, 0.02 % w/v of sodium azide was 
added to the buffer solution as an antimicrobial agent. Once the sample was mixed with 
the buffer, it was centrifuged at 12,000 rpm for 10 minutes to precipitate any particulate 
matter. After centrifugation, 550 μl of the supernatant was transferred to a 5 mm NMR 
tube for NMR analysis. 
3.1.6 NMR Data Acquisition and Processing 
NMR spectra were collected on a 700 MHz Bruker Avance III HD spectrometer 
(Bruker, ON, Canada). The Bruker 1-D NOESY gradient water suppression pulse 
sequence ‘noesygppr1d’ was used. Each sample was run for 128 scans to a total 
acquisition size of 128 k. The spectra were zero filled to 256 k, automatica lly phased, 
baseline corrected, and line-broadened by 0.3 Hz. The processed spectra were then 
exported to MATLAB (The MathWorks, MA, USA) for statistical analysis. Spectra were 
manually binned to reduce the size of the dataset. Each spectrum had the areas 
corresponding to water and urea removed before being normalized to remove effects of 
imperfect water signal suppression. The data set was then auto-scaled. 
3.1.7 Statistical Analysis 
Data visualization to determine sample structure and the presence of distinct 
groups within the dataset was conducted using principal component analysis (PCA). 
Hierarchical clustering analysis was also performed and is presented as a dendrogram 
coupled to a heatmap. Both PCA and the clustering analysis were performed using the 
online chemometrics software Metaboanalyst [160]. Percent differences for each 
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metabolite in each comparison group were also calculated using MATLAB (The 
MathWorks, MA, USA). 
Variable importance analysis based on random variable combination (VIAVC) 
[89] is a new feature selection method and was used for this analysis. Briefly, VIAVC 
provides a method for systematically resampling variables to determine if potentially 
synergetic effects exist between seemingly unimportant variables. The algorithm 
combines random permutation of variable inclusion or exclusion with a 10-fold cross 
validation (CV) of models to determine the optimal subset of variables that provide the 
most information about the differences between groups. It should be noted that even 
though the VIAVC script only employs CV, the way the algorithm is structured produces 
results that are no different from the method of double cross validation (DCV) that has 
been recommended elsewhere for the validation of metabolomics data sets [81]. The P-
values reported are calculated from a t-test of the distribution of scores based on whether 
the particular metabolite was included or excluded from the model. All of the VIAVC 
tests were carried out using MATLAB. A more detailed description of this complex 
method is available by Yun et al. [89]. Furthermore, for the behavioural analysis the 
average centre distance traveled in an open field was analyzed using a t-test and its 
relationship to metabolic outcomes was determined using Pearson R correlations in 
MATLAB.  
The biological significance of the important metabolites was investigated using 
two tools offered by Metaboanalyst. Metabolite set enrichment analysis (MSEA) uses a 
set of predefined metabolic pathways to identify significant and meaningful changes in 
functionally related metabolites within a biologically relevant context [91]. Data were 
entered into the MSEA as a list of metabolites and the Over-Representation Analysis 
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(ORA) algorithm was used. Pathway analysis was also conducted, which combines the 
results of pathway enrichment analysis with pathway topology to aid in the identification 
of the most relevant pathways involved in the conditions of the study [21]. The data were 
input as a list of metabolites, the Rat pathway library was chosen, and the ORA algorithm 
was selected using hypergeometric test. These two analysis tools were used in the 
identification of pathways to discuss in connection with significant metabolites. 
3.1.8 Metabolite Identification 
An in-house spectral database of pure metabolite substances was used to identify 
the majority of the metabolites in the spectra. Any metabolites not in our database were 
referenced using the online Human Metabolome Database [10]. 
3.2 Results and Discussion 
3.2.1 Metabolite Identification and Selection 
The purpose of this research was to identify urine metabolic signatures generated 
by cumulative or transgenerational ancestral stress that associate with or predict mental 
health outcomes. Urine represents the combined collection and concentration of 
metabolic wastes from an organism and thus it reflects individual phenotype, which is 
frequently affected by adverse experiences such as stress [23]. The initial results of PCA, 
when all metabolites were included, are shown in Figures 2A and 2B and revealed no 
separation of groups. The present approach used variable importance analysis based on 
random variable combination (VIAVC) as the feature selection method because it 
incorporates 10-fold cross-validation (CV) and random permutation methods in order to 
address the tendency of partial least squares discriminant analysis (PLS-DA) to over-fit 
data [80,81]. Furthermore, VIAVC method also allows extraction of informative 
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metabolites, exploits synergetic effects between metabolites, and excludes metabolites 
that vary randomly between samples. The P-value of each metabolite identified as 
significant by VIAVC, along with the percent differences for each, are displayed in Table 
1. Once the important metabolites were identified, they were used to re-run PCA (Figure 
10C and 10D) and hierarchical clustering (Figure 11A and 11B) analysis. Both of these 
unsupervised grouping methods correctly separated the experimental groups from the 
controls when considering only the variables identified by VIAVC. Not all of the 
metabolites identified by the VIAVC method for the two experimental groups were 
identical; however, there were a number of metabolites that were similar and these will be 
discussed later.  
The present results demonstrate that repeated prenatal stress in each of four 
generations (multigenerational stress, F4-SSSS group) and a single exposure to prenatal 
stress four generations removed (transgenerational stress, F4-SNNN group) produce 
urinary metabolic profiles that are unique when compared to a non-stress control lineage. 
This is evident by the clear separation of each of the stress lineages from the control 
group in the PCA scores plots that include only the metabolites identified by the VIAVC 
method (Figure 10C and 10D). Thus, the impact of stress in each stress lineage has 
caused a distinct alteration in metabolic activity. The multigenerational lineage 
demonstrates an impact of both direct and indirect stress exposure [148,161] while the 
transgenerational stress lineage unambiguously isolates the impact of inherited 
transgenerational programming, which transmits to the F4 generation [131,161]. The 
unique metabolic footprint of ancestral stress included 21 metabolites that were 
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significantly altered (Table 1). The heat map for each of the altered metabolites among 
the two stress lineages (Figure 11A and 11B) provides a graphical indication of whether  
 
Figure 10. Scores plots showing components 1 (X-axis) and 2 (Y-axis) of the PCA 
analysis for (A and C) F4-SSSS multigenerationally stressed lineage versus controls and 
(B and D) F4-SNNN transgenerationally stressed lineage versus controls. A and B 
provide the result of the analysis when on the metabolites identified by VIAVC were 
considered. The percentages shown along each axis indicate the amount of variance in the 
data set given by each componenet and the shaded ellipses designate the 95% confidence 
interval for each group. The controls are indicated by the red circles, the F4-SSSS by 
green triangles, and the F4-SNNN by green diamonds. 
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the metabolites were up- or down-regulated with respect to the control group. 
Furthermore, the percent differences given in Table 1 show that, when considering all 
metabolites identified from both stress lineages, a history of ancestral stress consistently 
reduces nine metabolites and elevates nine metabolites (Table 1). The dendrograms 
shown above the heat maps (Figure 11A and 11B) illustrate the results of hierarchical 
clustering analysis; this unsupervised method was able to correctly separate each stress 
lineage from the controls. 
Figure 11. Heat maps for (A) F4-SSSS multigenerationally stressed lineage versus 
controls and (B) F4-SNNN transgenerationally stressed lineage versus controls. The X- 
and Y-axis show the class and the metabolite identity, respectively. These heat maps 
visually indicate either up- or down-regulation of the metabolites presented in Table 1. 
The legend corresponding to the class label and the heat map for both figures is shown to 
the right of figure B. Abbreviations: 1-MN, 1-methylnicotinamide, IMP, inosine 
monophospate. The labels 1-MN, 1-MN.1 and 1-MN.2, as well as Histamine and 
Histamine.1, correspond to different resonance peaks of the same metabolite. The 
dendrogram at the top of each heatmap illustrates the results of the unsupervised 
hierarchical clustering analysis. 
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Figure 12. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in table 1. The p-values for the 
metabolic pathways are color coded with dark red being highly significant and white 
being least significant. The category “Intracellular Signalling” stands for intracellular 
signalling through the H2 receptor and histamine. 
 
The metabolites identified as varying significantly in the SSSS and SNNN 
lineages (Table 1) concur with our previous findings that variations induced by multi- vs. 
transgenerational stress [142,162] tend to be reflected in the intensity of the phenotype 
expression, and not the directionality. Accordingly, the directionality of the percent 
differences in 18 of 21 identified metabolites, either up- or down-regulation, was 
consistent between groups. Furthermore, when the two experimental groups (multi- and 
transgenerational) were plotted using a PCA scores plot (Figure 4) they highly overlap, 
suggesting similarity of metabolic profiles induced by multigenerational and 
transgenerational stress programming. Thus, irrespective of the frequency of prenatal 
stress exposure among the ancestral lineage, common metabolic pathways were 
reprogrammed that reflect the altered phenotype [142,162]. This observation aligns with 
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the finding of a coordinated pattern of epigenetic changes, including microRNAs that 
propagate from one generation to the next [142,143]. Accordingly, metabolic activity is 
dictated by genetic expression and epigenetic regulation of gene expression will be 
reflected by distinct levels of metabolic end products. 
Table 1. Display of the percent differences and P-values of metabolites that were 
determined to be significant for at least one of the stress lineages based on the VIAVC 
analysis (Control, n=7; F4-SSSS, n=6; F4-SNNN, n=6). 
 
 SSSS vs Control    SNNN vs Control 
 
P-value Percent Difference  P-value Percent Difference 
Formate 3.22x10-18 -25.06 
3.08x10-
12 
-31.19 
IMP  -6.98 1.61x10-9 -41.78 
1-MN 6.64x10-13 -11.66 
6.64x10-
13 
-29.02 
Histamine 3.30x10-24 -16.82 
5.03x10-
16 
-39.14 
Hippurate 1.84x10-11 26.9 3.56x10-6 27.64 
Tyrosine 8.37x10-17 -27.89 6.35x10-7 -20.43 
Fumarate  -8.48 0.36 -3.01 
Singlet 6.40 ppm  -13.96 2.84x10-6 4.75 
Thymidine  -3.69 5.07x10-3 -1.0 
Singlet 6.20 ppm  9.78 0.03 2.95 
Allantoin 4.94x10-8 32.58 1.54x10-4 17.2 
Galactose  -11.12 0.24 3.95 
Glucose 5.33x10-7 15.31 2.69x10-5 15.91 
Hydroxyacetone  -18.14 1.16x10-3 1.4 
Guanidoacetate 2.56x10-9 8.94  12.99 
Singlet 3.76 ppm 2.51x10-10 2.23 0.24 2.84 
Glycine 2.24x10-22 8.83  17.58 
Singlet 3.32ppm 2.5x10-4 19.64  45.87 
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Dimethylamine 1.75x10-10 62.07  15.17 
N6-Acetylysine  -11.01 0.017 -3.30 
Threonine 4.31x10-10 -24.75  -10.4 
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3.2.2 Metabolic Pathway Analysis 
The metabolites that were significantly altered by ancestral stress (Table 1) are 
diverse and involved in various pathways. Although one cannot conclusively rule out 
which of the potential metabolic pathways are relevant to phenotype, Pathway Analysis 
(PA) and Metabolite Set Enrichment Analysis (MSEA) identified a number of key 
metabolic pathways that these metabolites are involved in (Table 2 and Figure 5, 
respectively). The following pathways were selected from the outputs of PA and MSEA 
based on their biological relevance to mental health: catecholamine biosynthesis and 
tyrosine metabolism; intracellular signalling through the H2 receptor and histamine; 
histidine metabolism; and glycine, serine and threonine metabolism. The following list of 
metabolites from Table 1 are associated with the above pathways and will now be 
discussed individually: tyrosine, threonine, and histamine. 
Ancestral stress-induced up-regulation of tyrosine excretion supports the link to 
mental health and stress programming. Amino acid L-tyrosine is the precursor of multiple 
monoamine neurotransmitters including norepinephrine (NE), which is a central molecule 
directing the immediate physiological response to stress [125]. Obtained from the diet, 
animals in our study should had relatively identical levels of L-tyrosine [163]. However, 
both SSSS and SNNN groups had a significantly lower level of tyrosine being excreted, 
alluding to an elevated stress response [130,143] which consumes larger amounts of 
tyrosine to maintain elevated NE production in the stressed lineages. 
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Figure 13. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in table 1. The p-values for the 
metabolic pathways are color coded with dark red being highly significant and white 
being least significant. The category “Intracellular Signalling” stands for intracellular 
signalling through the H2 receptor and histamine. 
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Table 2. Overview of the metabolic pathways that were altered by ancestral stress 
compared to non-stress controls. All indicates the total number of metabolites listed in the 
pathways; hits indicate the number of significant metabolites identified in the pathways; 
the P-value is based on the enrichment analysis; FDR indicates false discovery rate; 
impact designates the pathway impact as determined by pathway topology analysis. 
 
 Stress may increase susceptibility to disease and allergies, autoimmune disease, 
and inflammation [164]. Threonine, an essential amino acid, stimulates thymus 
development and is a major building block of immunoglobulins [165]. In line with the 
notion of elevated stress responses induced by ancestral stress, threonine levels were 
reduced in both groups. As an important immuno-stimulant, low threonine excretion may 
be linked to higher demand by the immune system. 
Another immunomodulator that was reduced by a history of stress is histamine. 
Histamine is produced by decarboxylation of the essential amino acid L-histidine. It is 
active at sites of inflammation, stimulates gastric secretion, and also regulates immune 
function. Even low concentrations of histamine can be highly active in biological systems 
and therefore its synthesis, transport, storage, and release are carefully regulated [166]. 
Pathway Name All Hits P-value FDR Impact 
Aminoacyl-tRNA biosynthesis 67 3 0.043 0.77 0.10 
Methane metabolism 9 2 0.0047 0.23 0.17 
Glycine, serine and threonine metabolism 32 3 0.0059 0.23 0.32 
Histidine metabolism 15 1 0.168 0.85 0.15 
Phenylalanine, tyrosine and tryptophan 
biosynthesis 
4 1 0.047 0.77 1.0 
Tyrosine Metabolism 42 2 0.089 0.84 0.14 
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The stress-induced reduction in histamine in both the SSSS and SNNN groups may 
reflect either a lower conversion of L-histidine into histamine or a higher usage of 
histamine by the organism. Given that stress is often accompanied by exacerbated 
immune function [164], it is likely that histamine usage has been up-regulated, reflected 
by decreased excretion. 
The VIAVC method and the percent differences both identified hippurate as a 
significant metabolite; however, hippurate, which is a common urinary metabolite in 
mammals, is not related to metabolic pathways identified by MSEA and PA. There are a 
number of possible initial substrates for the production of hippurate, all of which are large 
polyphenols that enter the organism via the diet and undergo a series of reactions 
catalyzed by various enzymes and endogenous microbiota. The final step in the 
production of hippurate occurs in the mitochondrial matrix where benzoic acid, a remnant 
of the polyphenols, is conjugated with glycine [167]. Hippurate then enters the blood 
stream and is filtered out of vascular circulation by the kidneys. Its excretion is 
upregulated in human subjects with diabetes [167] and high levels of anxiety [168], both 
of which are common symptoms associated with prenatal stress [140,169,170]. Both 
experimental groups in this study displayed up-regulated hippurate excretion, which 
suggests discrete metabolic alteration linked to metabolic disorders and/or mental health.  
3.2.3 Behavioural Phenotype 
The distinct metabolic profiles of the SSSS and SNNN groups were associated 
with mental health outcomes. Open field locomotor profiles indicate a phenotype of 
higher emotional state and increased anxiety- like behaviour in the stressed lineages, as 
reflected by distance travelled in the centre of the open field arena. Rats that are less 
anxious will generally spend more time in the illuminated centre of the open field arena 
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whereas rats that are more anxious will avoid this open, lit space [171]. In the present 
study, an independent samples t-test compared average centre distance scores for male 
offspring from stressed and control lineages. There was a significant difference in the 
scores for control (M = 159.4, SD = 33.8) and stressed (M = 119.7, SD = 39.5) lineages 
(t(29) = -2.41, p < 0.05). The relationship between average distance scores and the 
relative concentrations of histamine and tyrosine indicated positive correlations for 
histamine [r = 0.55, p < 0.01 (one tailed)] and tyrosine [r = 0.21, p = 0.177 (one-tailed); 
Figure 6]. Thus, higher anxiety- like states were associated with lower histamine and 
lower tyrosine concentrations. 
 
 
Figure 14. Pearson correlations to assess the relationship between anxiety- like behaviour 
(i.e., average centre distance traveled) and the relative concentrations of histamine (A) 
and tyrosine (B). There were positive correlations between the distance score and 
histamine (r = 0.55, p = 0.0045), and tyrosine (r = 0.21, p = 0.177), indicating that a 
higher anxiety- like state was linked to lower histamine and tyrosine concentrations. 
3.3 Conclusions 
Using a 1H NMR-based metabonomics approach, perinatal programming caused 
by both remote and cumulative ancestral stress was manifested in altered metabolic 
profiles and anxious behaviour in the F4 generation. The programming was evident by 
changes in relative concentrations of a number of key metabolites, particularly hippurate, 
tyrosine, threonine and histamine. These metabolites are implicated in catecholamine 
biosynthesis, immune responses, and microbial host interactions in mammalian systems. 
The similarities between the metabolic profiles of multi- and transgenerational stress 
indicate that both cases share common metabolic pathways. When altered, these common 
metabolic pathways may either lead to or be reflective of pathophysiological processes 
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resulting in impaired health. Identification of metabolic pathways affected by ancestral 
stress will help to determine epigenetically regulated gene targets leading to stress-
associated diseases, such as mental health disorders. Ultimately, this will lead to a better 
understanding of the etiology of these diseases and potential biomarker discovery. 
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CHAPTER 4: TRANSGENERATIONAL STRESS PROGRAMMING OF LIVER 
METABOLOME 
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4.0 Introduction 
Social isolation acts as a mild to moderate stressor, activating the stress response, 
and leading to negative outcomes in humans [172,173] and animals [174]. The effects 
associated with stress are capable of impacting more than just the individual to whom the 
stress is applied. As discussed in the introduction to Chapter 3, stressors experienced 
during pregnancy have the ability to cause altered developmental outcomes in subsequent 
generations of offspring. Additional to the already discussed aspects of prenatal stress on 
offspring, there have also been specific studies analyzing how social isolation in pregnant 
animals impacts the lifespan of the offspring [175-177].  
Activation of the stress response results in the release of corticosteroids (cortisol 
in humans, corticosterone in rats) from the adrenal glands [125]. The stress response of 
offspring who experienced pre-natal maternal stress (PNMS) in utero is shown to be 
altered [129,140]. This alteration in the stress response will result in an altered pattern of 
corticosteroid release. Corticosteroids act on cells to convert energy stored in the cell into 
glucose through a process called gluconeogenesis [178]. As the liver is the primary site of 
gluconeogenesis, it is a logical tissue to analyze the metabolic effects of stress [179].  
 We performed 1H NMR metabolomics on liver homogenate samples from rats 
bred in both a trans- and multigeneration stress model (same experimental model as 
described in Chapter 3) using social isolation during pregnancy as the stressor. Our aim 
was to identify distinct profiles that could be used to discriminate between healthy 
controls and subjects whose ancestors were stressed. 
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4.1 Methods 
4.1.1 Animals 
This study involved Long-Evans rats raised at the Canadian Centre for 
Behavioural Neuroscience, University of Lethbridge vivarium. The animals were housed 
in pairs under a 12:12 h light/dark cycle with light starting at 07:30 h and the room 
temperature set at 22 °C. Rat chow food and water were available at libitum. All 
procedures were approved by the University of Lethbridge Animal Care Committee in 
compliance with the guidelines of the Canadian Council on Animal Care. 
4.1.2 Experimental Design 
To investigate the truly heritable metabolic phenotype, this study focuses on six-
month old male and female offspring from the F4 generation (reference for importance of 
F4). Four successive generations of timed-pregnant female rats were bred under 
consistent laboratory conditions. Parental female rats (F0) were socially isolated before 
and during pregnancy. For the multigenerational stress lineage (F4-SSSS; n=6) the 
pregnant daughters (F1), granddaughters (F2), and great granddaughters (F3) were also 
stressed before and during pregnancy. The transgenerational stress lineage (F4-SNNN; 
n=6) was bred by stressing only the F0 mothers and not the F1 – F3 mothers (see Figure 
1; S = stress, N = non-stress condition). Yolked controls were bred in parallel for each 
generation (Control, n=7), the mothers were housed in pairs until gestational day 21.  
4.1.3 Stress Procedure 
Pregnant dams were stressed using a social isolation stressor, which has been 
shown to result in mild psychosocial stress in rats [175]. Each dam was housed alone and 
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did not experience direct contact with any other rats from P 90 until her offspring were 
weaned. Control rats were housed in pairs until gestational day 21.  
4.1.4 Sample Collection and Preparation 
For fresh tissue collection, animals were placed into an induction chamber filled 
with 5% isoflurane (oxygen at 1.5 l/min). Upon successful deep anesthesia, the animals 
were administered 0.2 ml of sodium pentobarbital (Euthansol, Merck QC, Canada) by 
intracardiac infusion. After cardiac arrest, the liver (along with additional organ samples) 
were collected and immediately placed on dry ice at -80oC.  
4.1.5 Liver Homogenization  
Homogenization of the liver followed the protocols recommended by Beckonert et 
al. for extraction of polar and non-polar metabolites [43]. Briefly, frozen samples were 
separated into 150mg pieces and combined with 4ml/g methanol and 0.85ml/g of water. 
These were homogenized until a uniform mixture was obtained. An additional 4ml/g of 
water and 2ml/g of chloroform were added to the sample tube and vortexed for 30 
seconds. The sample was then centrifuged at 4°C for 15 minutes at 1500 rpm. One 
milliliter of supernatant was then removed and lyophilised overnight. The metabolites 
were reconstituted in 1ml of D2O. To prepare the samples for NMR spectroscopy, 450 μl 
aliquots of homogenate were transferred into 1.5 ml centrifuge tubes with 250 μl of 
phosphate buffer. The phosphate buffer was prepared as a 4:1 ratio of KH2PO4:K2HPO4 
in a 4:1 H2O:D2O solution to a final concentration of 0.5 M. The D2O came with 0.05 % 
by weight trimethylsilyl propanoic acid (TSP) as a chemical shift reference. To protect 
the metabolite profile integrity, 3mM of sodium azide was added to the buffer solution as 
an antimicrobial agent. Once the sample was mixed with the buffer, it was centrifuged at 
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12,000 rpm for 10 minutes to precipitate any particulate matter. After centrifugation, 550 
μl of the supernatant was transferred to a 5 mm NMR tube for NMR analysis. The 
remaining homogenate was stored at -80oC for future use. The lipid layer was not 
separated or collected, inclusion of the lipid solvent chloroform in the homogenization 
was used as it produced a cleaner spectrum. 
4.1.6 NMR Data Acquisition and Processing 
NMR spectra were collected on a 700 MHz Bruker Avance III HD spectrometer 
(Bruker, ON, Canada). The Bruker 1-D NOESY gradient water suppression pulse 
sequence ‘noesygppr1d’ was used. Each sample was run for 512 scans to a total 
acquisition size of 128 k. The spectra were zero filled to 256 k, automatically phased, 
baseline corrected, and line-broadened by 0.3 Hz. The processed spectra were then 
exported to MATLAB (The MathWorks, MA, USA) for statistical analysis. Spectra were 
manually binned to reduce the size of the dataset. Each spectrum had the areas 
corresponding to water and acetone removed before being normalized to remove effects 
of imperfect water signal suppression. The data set was then auto-scaled. 
4.1.7 Statistical Analysis 
Data visualization to determine sample structure and the presence of distinct 
groups within the dataset was conducted using PCA. Hierarchical clustering analysis was 
also performed, and is presented as a dendrogram coupled to a heatmap. Both PCA and 
the clustering analysis were performed using the online chemometrics software 
Metaboanalyst. Percent differences for each metabolite in each comparison group were 
also calculated using MATLAB (The MathWorks, MA, USA). 
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Variable importance analysis based on random variable combination (VIAVC) 
[89] is a new feature selection method and was used for this analysis. Briefly, VIAVC 
provides a method for systematically resampling variables to determine if potentially 
synergetic effects exist between seemingly unimportant variables. The algorithm 
combines random permutation of variable inclusion or exclusion with a 10-fold cross 
validation (CV) of models to determine the optimal subset of variables that provide the 
most information about the differences between groups. It should be noted that even 
though the VIAVC script only employs CV, the way the algorithm is structured produces 
results that are no different from the method of double cross validation (DCV) that has 
been recommended elsewhere for the validation of metabolomics data sets [81]. The P-
values reported are calculated from a t-test of the distribution of scores based on whether 
the particular metabolite was included or excluded from the model. All of the VIAVC 
tests were carried out using MATLAB.  
Similar to the previous study analyzing the urine metabolome, the biological 
significance of the important metabolites was investigated using MSEA and pathway 
analysis. 
4.1.8 Metabolite Identification 
An in-house spectral database of pure metabolite substances was used to identify 
the majority of the metabolites in the spectra. Any metabolites not in our database were 
referenced using the online Human Metabolome Database [10]. 
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4.2 Results and Discussion 
 Initial multivariate analysis of the data using PCA did not produce separation 
between the control and experimental groups as shown in Figures 13 and 14 (females and 
males respectively). VIAVC was used to identify important metabolites in each individual 
comparison. A new PCA model was then constructed for each comparison using only the 
optimal subset of metabolites as identified by VIAVC (Figures 15 and 16). The optimal 
subset of metabolites for each comparison is listed in Table 3 along with the p-value and 
percent difference of those metabolites. The AUC that corresponds to a multivariate ROC 
model made with the optimal subset of variables from each group is also listed in the 
table.  
 Along with the PCA models, hierarchical clustering and a heatmap of each 
comparison are provided (Figures 15 and 16). 
Figure 15. PCA scores using all variables for female F4-SNNN (A) and F4-SSSS (B). 
Plots show components 1 (x-axis) and 2 (y-axis) with the percentage of the variance 
explained by each component labelled on the axis. Ovals indicate the 95% confidence 
interval. 
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Figure 16. PCA scores using all variables for male F4-SNNN (A) and F4-SSSS (B). Plots 
show components 1 (x-axis) and 2 (y-axis) with the percentage of the variance explained 
by each component labelled on the axis. Ovals indicate the 95% confidence interval 
 
  
Figure 17. PCA scores using the optimal subset of variables for female F4-SNNN (A) 
and F4-SSSS (B). Plots show components 1 (x-axis) and 2 (y-axis) with the percentage of 
the variance explained by each component labelled on the axis. Ovals indicate the 95% 
confidence interval 
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Figure 18. PCA scores using the optimal subset of variables for male F4-SNNN (A) and 
F4-SSSS (B). Plots show components 1 (x-axis) and 2 (y-axis) with the percentage of the 
variance explained by each component labelled on the axis. Ovals indicate the 95% 
confidence interval. 
Figure 19. Heat maps for female (A) F4-SNNN multigenerationally stressed lineage 
versus controls and (B) F4-SSSS transgenerationally stressed lineage versus controls. The 
X- and Y-axis show the class and the metabolite identity, respectively. These heat maps 
visually indicate either up- or down-regulation of the metabolites presented in Table 3. 
The dendrogram at the top of each heatmap illustrates the results of the unsupervised 
hierarchical clustering analysis. 
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Figure 20. Heat maps for male (A) F4-SNNN multigenerationally stressed lineage versus 
controls and (B) F4-SSSS transgenerationally stressed lineage versus controls. The X- 
and Y-axis show the class and the metabolite identity, respectively. These heat maps 
visually indicate either up- or down-regulation of the metabolites presented in Table 3. 
The dendrogram at the top of each heatmap illustrates the results of the unsupervised 
hierarchical clustering analysis. 
 
Table 3. Display of the percent differences and p-values of metabolites that were 
determined to be significant in each comparison group. Each group listed is compared to 
the respective controls for each sex. A positive percent difference indicates an 
upregulation of the metabolite in the experimental group. 
Sex Lineage Metabolite p-value % Difference AUC 
Female SNNN sn-Glycero-3-
phosphocholine 
<0.001 -29.5  
  Succinate <0.001 -26.2  
  Pyruvate <0.001 -10.8  
  Niacinamide <0.001 -3.3 0.875 
  NADPH <0.001 -4.1  
  Glucose <0.001 -20.1  
  2-Oxovalerate <0.001 7.4  
      
 SSSS Cadaverine <0.001 6.8  
  Glucose <0.001 -5.3  
  ATP <0.001 33.3 0.875 
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  Malate <0.001 -15.4  
  Putrescine <0.001 6.7  
  Niacinamide <0.001 -7.7  
      
Male SNNN Hydroxyacetone <0.001 16.5  
  Niacinamde <0.001 18.3  
  ATP <0.001 16.4 0.883 
  Glutamine <0.001 15.9  
  Uracil <0.001 13.7  
      
 SSSS Glucose <0.001 -6.3  
  Valine <0.001 -12.2 0.889 
  NADPH <0.001 11.2  
 
Inspection of the VIAVC PCA graphs shows that in males and females, there is 
separation of groups in the SNNN lineages. However, in the SSSS lineage, the females 
show very little separation, while the males show similar separation to the SNNN group. 
This indicates a sex difference in how repeated ancestral stress affects the offspring, and 
suggests that there may be some resiliency being built up in the female offspring of 
repeated ancestral stress, but not the males [180]. The hierarchical clustering 
dendrograms pictured at the top of the heatmaps also indicate that the VIAVC metabolites 
are able to separate the controls from experimental cases. While this separation is not 
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perfect, it still illustrates that differences do exist in the metabolic profiles of liver tissues 
of subjects in this experiment.  
Figure 21. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in Table 3 for the Female SNNN 
group. The Pp-values for the metabolic pathways are color coded with dark red being h 
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Figure 22. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in Table 3 for the Female SSSS 
group. The Pp-values for the metabolic pathways are color coded with dark red being 
highly significant and white being the least. 
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Figure 23. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in Table 3 for the Male SNNN 
group. The p-values for the metabolic pathways are color coded with dark red being 
highly significant and white being the least significant. 
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Figure 24. Summary plot for the over representation analysis of metabolic pathways 
associated with the complete list of metabolites shown in Table 3 for the Male SSSS 
group. The p-values for the metabolic pathways are color coded with dark red being 
highly significant and white being the least significant. 
 
While the specific metabolites that were identified in each group are different, 
many are related by biochemical pathways related to cellular energy management. This is 
supported by the MSEA analysis for all comparisons returning glycolysis and 
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gluconeogenesis as pathways that were impacted by the ancestral stress. Glycolysis 
occurs in the cytosol of the cell and converts glucose into pyruvate, which then enters the 
citric acid cycle in the mitochondria. Gluconeogenesis is a process whereby non-
carbohydrate substrates, such as proteins and fats, are converted to glucose. Both of these 
processes prepare molecules in the body for energy production.  
Of the identified metabolites, succinate, pyruvate, malate, and glucose are all 
involved in normal energy production through the citric acid cycle [181]. Reduction of all 
of these metabolites across the various groups could indicate a reduction or depletion of 
energy derived via the citric acid cycle. Conversely, hydroxyacetone and 2-oxovalerate 
are both ketone bodies that originate from the metabolism of fats for energy use [182]. 
Increases of both of these metabolites suggest a greater a reliance on alternative energy 
sources as a result of and altered stress response induced by ancestral stress.  
Niacinamide is a component of NADPH, which acts as a reducing agent in energy 
producing reactions within the cell [183]. Both Niacinamide and NADPH were altered in 
this study. ATP, the primary energy currency of cells, was also altered in two of the 
groups. Taken together, these results indicate that ancestral stress impacts the energy 
metabolism in multiple generations of offspring. This is most likely mediated through 
aberrant cortisol levels resulting from a dysfunctional stress response.  
Increased stress has consequences for the immune system. Excessive activation of 
the stress response lowers immune function and increases the likelihood of contracting 
disease or growing bacterial infections [184]. There was a moderate increase in the levels 
of putrescine and cadaverine in the female SSSS group. These two metabolites have been 
linked to the presence of unhealthy bacterial colonies in the organism and suggest that 
these subjects were less protected against infection [185]. 
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4.3 Conclusion 
Although no coherent pattern of specific metabolites was consistently affected in 
all the experimental groups, the metabolic functions of the important metabolites were 
related. The results support the theories that prenatal stress alters the stress response of 
the offspring, and that this altered response will effect metabolism. Importantly, this study 
illustrates that cumulative and remote ancestral stress can have metabolic repercussions 
multiple generations removed from the stressful event.   
These results may also suggest that social isolation is less stressful than the forced 
swim task and restraint. The results from the urine study in Chapter 3 were more robust 
than those obtained analyzing the liver. This may be because the liver metabolome is less 
impacted by the ancestral stressor; however, there is the possibility that the stressors 
applied in the Chapter 3 study were more intense than those applied to the current study, 
and thus elicited a stronger response. This theory cannot be tested with the present data as 
the information was collected from two different sample types. Further research could 
investigate if differential metabolic responses result from different stress regimes.  
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CHAPTER 5: GENERAL DISCUSSION AND CONCLUSIONS 
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5.1 Summary 
 The objective of this thesis was to investigate the metabolic alterations caused by 
ancestral transgenerational prenatal stress (TPS) and ancestral multigenerational prenatal 
stress (MPS). As far as we are aware, this work is the first to study the metabolic effects 
in the F4 generation offspring of TPS and MPS maternally stressed lineages in a rat 
cohort. In Chapter 1, the general theory of metabolomics and how it translates to a 
measure of phenotypic expression was discussed. As the majority of the work described 
in this thesis involved the development and implementation of metabolomics experiments 
at the University of Lethbridge, Chapter 2 discussed NMR theory as it applies to 
metabolomics, and it outlined the workflow and procedures followed when performing 
NMR metabolomics, and provided a summary review of representative studies that 
applied NMR metabolomics to study the brain. In Chapter 3, 1H NMR of urine samples 
from TPS and MPS F4 male offspring were studied to investigate the metabolic changes 
that occur as a result of ancestral stress. Chapter 4 also described 1H NMR, this time to 
analyze the metabolome of liver homogenates from TPS and MPS F4 male and female 
offspring. Combined, these studies offer a method for monitoring the long term impact 
that ancestral stress can have on metabolism. 
5.2 Ancestral Stress Alters Metabolism 
 The effects of ancestral stress on offspring have been well documented. While a 
large amount of research has focussed on cognitive and behavioural effects, as well as 
reprogramming of the stress response, this study focussed on the metabolic changes that 
accompany these other alterations. As the stress response utilizes signalling hormones and 
releases cortisol, a major metabolism regulator, it is intuitive that metabolic differences 
will be present. Indeed, this is what was observed. Of the metabolic alterations that were 
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detected, all significant changes were directly linked to processes that the literature 
indicates are either involved in or affected by the stress response. This supports the view 
that metabolism plays an integral role in body function and can serve as a sensitive 
measure and biomarker of phenotype. 
5.3 Limitations and Considerations for Future Research 
The present series of studies were limited to the analysis of the F4 offspring in a 
controlled breeding lineage. Analysis of all previous generations would be valuable in 
showing how the effects of stress either increase or plateau with time. It would also be 
interesting to analyse future generations to see if or when effects begin to diminish. For 
the urine study presented in Chapter 3, ideally one would analyse more than one urine 
sample per subject in order to get a more accurate measure of the individual metabotypes, 
as well as to mitigate any abnormal variation that may have been present at the time of 
collection. As the rats were sacrificed when the urine was collected, the collection method 
would need to be altered to obtain multiple samples. For the liver study in Chapter 4, 
multiple samples could have been prepared from each liver. This would have helped to 
quantify the amount of variation present in the samples due to experimental error. 
Additionally, it would have been valuable to analyze the epigenome in order to confirm, 
rather than infer, that epigenomic mechanisms were heavily involved in the transfer of the 
TPS phenotype. Similar work has been performed in earlier studies [126, 131, 142, 148, 
149, 150, 162]. 
The stress applied to the rats differed in the two studies presented, ranging from 
restraint and forced swimming to social isolation. It would be worthwhile to design 
experiments that involved the same analysis of the different stress procedures to 
determine what, if any, differences exist in the metabolic response to different stressors. 
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Future studies should be designed with metabolomics in mind and have multiple 
sample types available for each subject. A weakness of the work presented in this thesis is 
that the urine study and the liver study used different subjects. Ideally, we would have 
been able to have liver and urine from the same animals which would facilitate 
correlating tissue abnormalities with urinary markers. If urine, blood, CSF, and multiple 
tissues were available for every subject, multiple correlations could be made and more 
information would be available to move forward with for biomarker studies.  
5.4 Conclusions 
 The results of this work indicate that ancestral stress alters the phenotype of 
offspring for up to four generations after the stressor, and that this change in phenotype 
can be detected in the metabolic profiles of urine and liver homogenate. Further 
generations may be also affected, which remains to be determined. The metabolic 
changes point to altered host-microbiome interactions, dysregulated monoamine 
signalling, altered immune function, and altered energy metabolism. All these functions 
suggested by the metabolic markers have previously been shown to be affected by 
prenatal stress. Additionally, the results from the study in Chapter 3 were correlated with 
behavioural outcomes, showing that the metabolic markers can be linked to other 
phenotypic measures. The net results of this study validate the potential of using 
metabolomics for studies of health and disease. It also highlights the potential that 
metabolomics has to serve as a technique to discover and monitor novel bio-markers. 
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